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Abstract 
Cancer is a major cause of human death worldwide, and one of the very real 
challenges is how to control treatment resistance. An additional challenge is the co-
morbidity of cancer, with certain infections complicating its management. 
Radiotherapy (RT) is considered the first line of treatment for most superficial cancers, 
as these malignancies tend to respond well to radiation. The use of hypofractionated 
treatment may be beneficial for certain tumours, but hypofractionation may result in 
severe side-effects from normal tissue toxicity from which the patient may not recover. 
To circumvent this, radiation modifying agents that potentiate the tumour inactivating 
effects of ionising radiation and thereby lead to a reduction in radiation dose and 
prevent normal tissue toxicity, can be utilised. Magnetic fields have long been 
suggested as potential enhancers of radiation effects. Studies on the combined 
biological effects of radiofrequency fields (RFF) and ionising radiation are virtually non-
existent. The use of RFF adjuvant to radiotherapy may be beneficial, as they have 
been shown to exhibit in vitro radiosensitising and radioprotective effects in malignant 
and normal cells, respectively, with the possibility of a significant dose reduction. There 
is, however, a need to understand the mechanisms by which these RFF influence 
radiosensitivity so that they can be employed efficiently as radiotherapy modulators. 
The main goal of radiotherapy is to kill tumour cells and spare normal tissue, and a 
good modifying agent would be one that sensitises the tumour whilst protecting normal 
tissue.  
This study assessed the effect of radiofrequency fields (RFF), modulated at 100, 1000, 
2000 and 4000 Hz, on the radiosensitivity of four cell lines: a p53 mutant melanoma 
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cell line, MeWo; a p53 wild-type melanoma cell line, Be11; a p53 mutant prostate 
cancer cell line, DU145; and a p53 wild-type normal lung fibroblast cell line, L132. The 
radiomodulatory effect of radiofrequency fields was evaluated using the colony assay. 
The 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), superoxide 
dismutase (SOD) and micronucleus assays were used to assess the possible 
mechanisms by which radiofrequency fields influence the radiosensitivity of cells. 
 
The data demonstrate that radiofrequency fields are more efficient in modulating large 
fractional doses of X-rays and could find application in hypofractionated radiotherapy 
as adjuvants, especially for tumours with low alpha/beta ratios. This can have a 
positive impact on the management of patients with superficial tumours that may be 
resistant to low fractional doses of radiation. Radiofrequency fields modulate cellular 
radiosensitivity in a frequency- and cell type-dependent manner and their effects 
appear to be linked to p53 status. Cellular responses such as metabolism, DNA 
damage processing (based on micronuclei formation), and abnormal proliferation 
(based on binucleation) seem to be underlying factors mediating the radiomodulatory 
effects of radiofrequency fields.  
 
Mechanisms by which radiofrequency fields can possibly modulate radiosensitivity 
are: amplification of radiation-induced genotoxicity, cell cycle arrest, and disturbance 
of other cellular biochemical processes that lead to alteration of homeostasis. 
Alternative ways by which RFF affect radiosensitivity are: interfering with the synthesis 
and function of charged proteins in the cell leading to programmed cell death or 
premature cell ageing, perturbation of intracellular calcium ions which can trigger 
Stellenbosch University https://scholar.sun.ac.za
v 
apoptotic or necrotic cell death, and/or modulating the expression of Bcl-2 family 
proteins.  
Given this complexity, a potential use of radiofrequency fields as a non-invasive 
therapeutic modality would require standardisation to establish reproducibility. A more 
detailed understanding of how radiofrequency fields interact with ionising radiation 
would also prove beneficial in the broader field of radiation protection. 
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Opsomming 
 
Kanker is wêreldwyd ‘n belangrike oorsaak van die dood in mense, en een van die 
werklike uitdagings is hoe om weerstand teen behandeling te voorkom. ‘n Addisionele 
uitdaging is dat die komorbiditeit van kanker en infeksies die behandeling bemoeilik. 
Bestralingsterapie word by voorkeur as die eerste keuse van behandeling vir die 
meeste van die oppervlakkige kankers beskou, want hierdie kwaadaardige siektes is 
kwesbaar vir bestraling. Die gebruik van hipofraksioneerde behandeling mag 
voordelig vir die behandeling van sekere tumore wees, maar hipofraksionering mag 
moontlik bykomstige nadelige gevolge in die vorm van onomkeerbare 
lewensbedreigende toksisiteit inhou. Om dit te voorkom, kan stralingsmodifiërende 
strategieë gebruik word, met die vermoë om die tumorinaktivering te potensieer, 
bestralingsdosis te verlaag en weefseltoksisiteit van normale weefsel te verminder.  
Magnetiese velde word lankal as ‘n potensiële versterker van stralingseffekte beskou.  
Studies oor die gekombineerde biologiese uitwerking van radiofrekwensievelde (RFV) 
en gëioniseerde bestraling is selde gerapporteer. Die benutting van 
radiofrekwensievelde saam met bestraling mag voordelig wees, want dit is bewys dat 
hierdie kombinasieterapie in vitro daarin slaag om maligne en normale selle teen 
bestralingskade te beskerm, omdat die bestralingsdosis aansienlik verlaag kan word. 
Dit is egter nodig dat die meganismes, waardeur radiofrekwensievelde die 
bestralingsensitiwiteit beїnvloed, opgeklaar word sodat dit voordelig as modulators 
van radioterapie aangewend kan word.  Die hoofdoel van radioterapie is om tumorselle 
dood te maak en om normale selle te beskerm. ‘n Nuttige modulator is dié wat normale 
selle beskerm, terwyl dit tumorselle kwesbaar maak. 
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Hierdie studie het die effek van radiofrekwensievelde (RFV) gemoduleerd met 100, 
1000, 2000, en 4000 Hz, op die verhouding van die radiosensitiwiteit van vier sellyne 
evalueer: ‘n p53-mutant melanoomsellyn, MeWo; ‘n p53-wildetipe melanoomsellyn, 
Be11; ‘n p53-mutant prostaatkankersellyn, DU145; en ‘n p53-wildetipe normale long-
sellyn, L132.  Die stralingsregulerende effek van radiofrekwensievelde is bereken deur 
die gebruik van kolonie-essaiëring.  Die MTT, SOD en mikrokerntoetse is gebruik om 
die moontlike meganismes waardeur radiofrekwensievelde die radiosensitiwiteit van 
selle beїnvloed, te bepaal.   
 
Die data bewys dat radiofrekwensievelde meer doeltreffend is wanneer dit toegepas 
word op modulering van groot gefraksioneerde dosisse X-strale en mag dien as 
bykomende hipofraksioneerde stralingsterapie, veral in tumore met lae alfa/beta-
verhoudings.  Hierdie addisionele voordeel kan verder benut word by die behandeling 
van pasiënte met oppervlakkige tumore wat weerstandig is teen lae gefraksioneerde 
stralingsdosisse. Radiofrekwensievelde moduleer die radiosensitiwiteit van selle op ‘n 
frekwensie- en seltipe-afhanklike wyse en die uitwerking blyk gekoppel te wees aan 
p53-status. Sellulêre reaksies soos metabolisme, DNS-skadeprosessering (gebaseer 
op mikrokernvorming), en abnormale proliferasie (gebaseer op dubbelkernvorming) 
skyn onderliggende faktore te wees wat die radiomodulerende effekte van 
radiofrekwensievelde medieer. 
 
Meganismes waardeur radiofrekwensievelde moontlik die radiosensitiwiteit kan 
reguleer, is: versterking van bestralingsgeїnduseerde geentoksisiteit, selsiklusarres, 
en versteuring van ander sellulêre biochemiese prosesse wat lei tot versteuring van 
homeostase. Alternatiewe meganismes waardeur RFV radiosensitiwiteit bëinvloed, is: 
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versteuring van die sintese en funksionering van intrasellulêre polêre proteїene wat lei 
tot geprogrammeerde seldood of premature veroudering van selle, ontwrigting van 
intrasellulêre kalsiumioonekwilibrium wat apoptose of nekrotiese seldood kan sneller 
en/of die uitdrukking van Bcl-2- familieproteїene kan moduleer.  
 
Teen die agtergrond van hierdie ingewikkelde oorwegings, verg die potensiële 
benutting van radiofrekwensievelde as ‘n nie-indringende terapeutiese modulator 
standaardisasie om herhaalbaarheid vas te stel. ‘n Meer gedetailleerde begrip van 
hoe presies die interaksie van radiofrekwensievelde met geїoniseerde bestraling 
verklaar kan word, mag ook van toepassing wees op die gebied van beskerming teen 
bestraling op velerlei ander gebiede. 
 
  
Stellenbosch University https://scholar.sun.ac.za
ix 
 
Acknowledgements  
 
Firstly, I would like to express my sincere gratitude to my supervisors Prof Akudugu 
and Dr Serafin who were willing to go out of their way to help me make this thesis a 
success. I also thank Prof J Lochner for translating my abstract into Afikaans. 
 
I would also like to thank my father, Mr SD Chinhengo, for teaching me to value 
education and to be persistent towards worthy goals.  
 
To my mother, Mrs C Chinhengo, I say thank you for all your support and your prayers.  
 
I am also grateful to all my siblings (Alice, Alec, Esher, Beauty, Abu, Abi, Beaula, Fai, 
Bule, Fari and Janet) for encouraging me and believing in me.  
 
To my children, Tawananyasha and Tinevimbo, I would like to say thank you for being 
my reasons to keep pushing. I appreciate and love you a lot.  
 
To my friends and extended family all over the world and my fellow students in the 
department, I thank you for all your support. 
 
Last, but not the least, financial assistance from the Faculty of Medicine and Health 
Sciences (Stellenbosch University), the Harry Crossley Foundation, and the South 
African National Research Foundation (NRF) is acknowledged. 
 
Opinions expressed and the conclusions arrived at in this dissertation are those of the 
author, and are not necessarily to be attributed to the Faculty of Medicine and Health 
Sciences (Stellenbosch University), the NRF or the Harry Crossley Foundation.  
Stellenbosch University https://scholar.sun.ac.za
x 
 
Dedications 
 
I dedicate this study to my children, whose love kept me going and whose presence 
gave me strength. 
  
Stellenbosch University https://scholar.sun.ac.za
xi 
 
CONTENT              PAGE 
 
Declaration           ii 
Abstract           iii 
Opsomming           vi 
Acknowledgements          ix 
Dedication           x  
List of Tables          xiv 
List of Figures          xvi 
List of Abbreviations         xx
           
CHAPTER 1           1 
1.1. Introduction and Rationale        2 
1.2. Literature Review         7 
1.2.1. Radiation Therapy Overview        7 
1.2.2. Targeted Therapy         10 
1.2.3. Combination Therapy         11  
1.2.4. The Co-morbidity of Cancer and Other Infections, and the Possible Influence of EMF 
on the Management of Such Cancers      13 
1.2.5. Effects of Electromagnetic Fields       15 
1.2.5.1. Electric Fields         15 
1.2.5.2. Magnetic Fields         18 
1.2.5.3. Radiofrequency Fields        20 
1.3. Problem Statement         24 
1.4. Research Question         25 
1.5. Hypothesis          26 
1.6. Aims and Objectives         27 
Stellenbosch University https://scholar.sun.ac.za
xii 
 
1.7. Delineations          28 
1.8. Limitations          29 
 
CHAPTER 2           30 
2. Materials and Methods         31 
2.1. Study Location          31  
2.2. Cell Lines and Culture Maintenance       31 
2.3. Preparation of Cell Cultures for Experiments      33 
2.4. Irradiation of Cell Cultures        33 
2.5. Radiofrequency Generation and Exposure      34 
2.6. Clonogenic Cell Survival Assay        38 
2.7. Effect of Radiofrequency Fields on Plating Efficiency      40 
2.8. Radiomodulatory Effects of Radiofrequencies       40 
2.9. Assessment of Metabolic Activity        41 
2.10. Measurement of Cytosolic Superoxide Dismutase (SOD) Activity    43 
2.11. Assessment of DNA Damage Response       44 
2.12. Data Analysis           46
         
 
CHAPTER 3           47 
3. Results           48 
3.1. Effect of Radiofrequency Field Exposure on Plating Efficiency    48  
3.2. Radiosensitivity and Radiomodulatory Effect of Radiofrequency Fields  49 
3.3. Summary of Relative Cellular Radiosensitivity      60 
3.4. Effect of Radiofrequency Fields Modulated at Higher Frequencies on Radiosensitivity
            62 
3.5. Effect of Radiofrequency Fields on Radiation-Induced Metabolic Changes  66 
3.6. Relationship between Radiosensitivity and Metabolic Activity    74 
Stellenbosch University https://scholar.sun.ac.za
xiii 
 
3.7. Effect of a Radiofrequency Field on Radiation-Induced Changes in Superoxide Dismutase 
(SOD) Activity          77 
3.8. Relationship between Radiosensitivity and SOD Activity    83 
3.9. Effect of Radiofrequency Fields on Radiation-Induced Micronucleus Frequency 84 
3.10. Relationship between Radiosensitivity and Micronucleus Yield   96  
3.11. Relationship between Radiosensitivity and Binucleation    98 
 
CHAPTER 4           100 
4. Discussion          101 
4.1. Intrinsic Radiosensitivity and Radiomodulatory Effect of Radiofrequency Fields 102 
4.2. Effect of Radiofrequency Fields on Radiation-Induced Changes in Metabolic Activity and 
its Relation to Overall Cell Survival       105  
4.3. Effect of Radiofrequency Fields on Radiation-Induced Changes in Superoxide Dismutase 
(SOD) Activity and its Relation to Overall Cell Survival     107 
4.4. Effect of Radiofrequency Fields on Radiation-Induced Micronucleus Frequency, and the 
Possible Impact on Cell Survival        108 
4.5. Effect of Radiofrequency Fields on Radiation-Induced Changes in Binucleation  110
     
 
CHAPTER 5           113 
5. Conclusion          114 
 
Possible Future Avenues         116
    
References           118 
 
Appendices           149
       
Stellenbosch University https://scholar.sun.ac.za
xiv 
 
LIST OF TABLES 
 
Table 2.1:  Estimated peak electric field (E), magnetic flux density (B), and current density (J) induced 
at a distance (d) from the axis of a 29-cm plasma ray tube     37 
Table 2.2: Summary of cell numbers seeded at each radiation dose of X-rays delivered acutely 38 
Table 3.1: Summary of plating efficiency modifying factors for DU145, MeWo, Be11, and L132 cell 
lines following exposure to 100, 1000, 2000, and 4000-Hz modulated radiofrequency 
fields. Data are presented as the mean ± SEM from 3 independent experiments 48 
Table 3.2:  Summary of radiobiological parameters for the DU145 cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic 
coefficients of cell inactivation, respectively. ?̅? denotes the mean inactivation dose (area 
under the cell survival curve). Data are presented as the mean ± SEM from 3 independent 
experiments         50 
Table 3.3:  Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and 
?̅? values presented in Table 3.2 for the DU145 cell line according to Equation (2.4). Errors 
were calculated using error propagation formulae for ratios    51 
Table 3.4:   Summary of radiobiological parameters for the MeWo cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic 
coefficients of cell inactivation, respectively. ?̅? denotes the mean inactivation dose (area 
under the cell survival curve). Data are presented as the mean ± SEM from 3 independent 
experiments         53 
Table 3.5:   Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.4 for the MeWo cell line according to Equation (2.4). Errors 
were calculated using error propagation formulae for ratios    54 
Table 3.6:   Summary of radiobiological parameters for the Be11 cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic 
coefficients of cell inactivation, respectively. ?̅? denotes the mean inactivation dose (area 
under the cell survival curve). Data are presented as the mean ± SEM from 3 independent 
experiments         56 
Table 3.7:   Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.6 for the Be11 cell line according to Equation (2.4). Errors 
were calculated using error propagation formulae for ratios    57 
Table 3.8:   Summary of radiobiological parameters for the L132 cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic 
coefficients of cell inactivation, respectively. ?̅? denotes the mean inactivation dose (area 
under the cell survival curve). Data are presented as the mean ± SEM from 3 independent 
experiments         59 
Stellenbosch University https://scholar.sun.ac.za
xv 
 
Table 3.9:   Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.8 for the L132 cell line according to Equation (2.4). Errors 
were calculated using error propagation formulae for ratios    60 
Table 3.10:   Summary of relative radiosensitivity of DU145, L132, Be11, and MeWo cell lines based 
on SF2, SF6, and ?̅?          61 
Table 3.11:   Modifying factors (MF), relative to X-ray treatment alone, derived from the relative 
metabolic activities presented in Figure 3.9 for the DU145 cell line, as described in Section 
2.9. Errors were calculated using error propagation formulae for ratios  68 
Table 3.12:   Modifying factors (MF), relative to X-ray treatment alone, derived from the relative 
metabolic activities presented in Figure 3.10 for the MeWo cell line, as described in Section 
2.9. Errors were calculated using error propagation formulae for ratios  70 
Table 3.13:   Modifying factors (MF), relative to X-ray treatment alone, derived from the relative 
metabolic activities presented in Figure 3.11 for the Be11 cell line, as described in Section 
2.9. Errors were calculated using error propagation formulae for ratios  72 
Table 3.14:   Modifying factors (MF), relative to X-ray treatment alone, derived from the relative 
metabolic activities presented in Figure 3.12 for the L132 cell line, as described in Section 
2.9. Errors were calculated using error propagation formulae for ratios  74 
Table 3.15:   Modifying factors (MF), relative to X-ray treatment alone, derived from the superoxide 
dismutase (SOD) activities presented in Figures 3.16-3.19 for the DU145, MeWo, Be11, 
and L132 cell lines, as described in Section 2.10. Errors were calculated using error 
propagation formulae for ratios       82 
Table 3.16:   Modifying factors (MF), relative to X-ray treatment alone, derived from the micronucleus 
frequency presented in Figures 3.21, 3.23, 3.25, and 3.7 for the DU145, MeWo, Be11, and 
L132 cell lines, respectively, as described in Section 2.11. Errors were calculated using 
error propagation formulae for ratios      95 
Table 3.17:   Modifying factors (MF), relative to X-ray treatment alone, derived from the binucleation 
indices presented in Figures 3.22, 3.24, 3.26, and 3.8 for the DU145, MeWo, Be11, and 
L132 cell lines, respectively, as described in Section 2.11. Errors were calculated using 
error propagation formulae for ratios      98 
 
 
    
 
  
Stellenbosch University https://scholar.sun.ac.za
xvi 
 
LIST OF FIGURES 
 
Figure 1.1:  Radiotherapy-induced skin burns on a patient treated for carcinoma of the base of the 
tongue (from Lee et al., 2002)       4 
Figure 1.2:  Example of radiotherapy-induced late effects and ulceration (from Jacobson et al., 2017)
           4 
Figure 1.3: Radiation interacts with cellular DNA directly or indirectly (adapted from Basker et al., 2012) 
            7 
Figure 1.4: Radiation damage triggers a signal that is relayed from ATM to p53, leading to cell death 
(adapted from Cohen-Jonathan et al., 1999)       8 
Figure 1.5: HHV-8 associated Kaposi’s Sarcoma (National Cancer Institute visuals online, 2001; 
https://visualsonline.cancer.gov/details.cfm?imageid=2168)    13 
Figure 1.6: HPV-mediated genital warts associated with cervical cancer (Feigwarzen Bilder; 
https://www.warzen-hilfe.com/feigwarzen-welcher-arzt/)    14 
Figure 1.7:  The Fenton reaction: conversion of hydrogen peroxide (H2O2) into a highly reactive 
hydroxyl radical (OH) in the presence of iron (Phillips et al., 2008)   23 
Figure 2.1:  Photograph of the Precision MultiRad 160 X-ray irradiator (door opened) showing cell 
culture flasks on the turntable        34 
Figure 2.2: (A) Photograph of the electromagnetic field (EMF) exposure system, with the PERL M+ 
inverted on an appropriately cut styrofoam box. (B) A 2-dimensional schematic diagram 
showing the top and bottom cell culture planes of the 224 flask matrix. In the set-up, the 
plasma ray tube is centred horizontally above the cell culture flasks, such that the induced 
magnetic field (B) is parallel to the base of a flask and the induced electric field (E) in the 
culture medium is parallel to the width of the flask     35  
Figure 3.1:  Clonogenic survival curves for the DU145 cell line after X-ray irradiation alone (black) and 
in combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). 
RFF exposure was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival 
curves were obtained by fitting data from three independent experiments to the linear-
quadratic model (Equation 2.2)       49 
Figure 3.2:  Clonogenic survival curves for the MeWo cell line after X-ray irradiation alone (black) and 
in combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). 
RFF exposure was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival 
curves were obtained by fitting data from three independent experiments to the linear-
quadratic model (Equation 2.2)       52 
Figure 3.3:  Clonogenic survival curves for the Be11 cell line after X-ray irradiation alone (black) and 
in combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). 
RFF exposure was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival 
Stellenbosch University https://scholar.sun.ac.za
xvii 
 
curves were obtained by fitting data from three independent experiments to the linear-
quadratic model (Equation 2.2)       55 
Figure 3.4:  Clonogenic survival curves for the L132 cell line after X-ray irradiation alone (black) and in 
combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). RFF 
exposure was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival 
curves were obtained by fitting data from three independent experiments to the linear-
quadratic model (Equation 2.2)        58 
Figure 3.5:  Cell survival data of the DU145 cell line for various radiofrequency field treatments at (A) 
2 Gy and (B) 6 Gy         62 
Figure 3.6:  Cell survival data of the MeWo cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy         63 
Figure 3.7: Cell survival data of the Be11 cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy         64 
Figure 3.8:  Cell survival data of the L132 cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy         65 
Figure 3.9: Relative metabolic activities for the prostate cancer cell line, DU145: (A) 30 min and (B) 
18 h after treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz 
modulated radiofrequency fields       67 
Figure 3.10: Relative metabolic activities for the melanoma cell line, MeWo: (A) 30 min and (B) 18 h 
after treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz 
modulated radiofrequency fields       69 
Figure 3.11: Relative metabolic activities for the melanoma cell line, Be11: (A) 30 min and (B) 18 h after 
treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz modulated 
radiofrequency fields        71 
Figure 3.12: Relative metabolic activities for human lung fibroblasts, L132: (A) 30 min and (B) 18 h after 
treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz modulated 
radiofrequency fields        73 
Figure 3.13: Plot of modifying factors from metabolic activity (measured 30 min after treatment) as a 
function of modifying factors from clonogenic cell survival for 4 cell lines: (A) combined 
treatment with 100-Hz modulated RFF and (B) combined treatment with 1000-Hz 
modulated RFF. Dashed lines represent the 95% confidence interval  75 
Figure 3.14: Plot of modifying factors from metabolic activity (measured 18 h after treatment) as a 
function of modifying factors from clonogenic cell survival for 4 cell lines: (A) combined 
treatment with 100-Hz modulated RFF and (B) combined treatment with 1000-Hz 
modulated RFF. Dashed lines represent the 95% confidence interval  76 
Figure 3.15: Standard curve used to determine the concentration of cytosolic superoxide dismutase 
(SOD) from absorbance measurements      77 
Figure 3.16: Superoxide dismutase concentration in DU145 cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control 
(medium; red horizontal line) and X-ray+RFF treatment was compared with positive control 
Stellenbosch University https://scholar.sun.ac.za
xviii 
 
(1000 Hz; blue horizontal line), to generate relative SOD activities which were used to 
derive modifying factors, as described in Section 2.10    78 
Figure 3.17: Superoxide dismutase concentration in MeWo cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control 
(medium; red horizontal line) and X-ray+RFF treatment was compared with positive control 
(1000 Hz; blue horizontal line), to generate relative SOD activities which were used to 
derive modifying factors, as described in Section 2.10    79 
Figure 3.18: Superoxide dismutase concentration in Be11 cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control 
(medium; red horizontal line) and X-ray+RFF treatment was compared with positive control 
(1000 Hz; blue horizontal line), to generate relative SOD activities which were used to 
derive modifying factors, as described in Section 2.10    80 
Figure 3.19: Superoxide dismutase concentration in L132 cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control 
(medium; red horizontal line) and X-ray+RFF treatment was compared with positive control 
(1000 Hz; blue horizontal line), to generate relative SOD activities which were used to 
derive modifying factors, as described in Section 2.10    81 
Figure 3.20: Plot of modifying factors from superoxide dismutase activity (measured 30 min after 
treatment) as a function of modifying factors from clonogenic cell survival for 4 cell lines, 
following combined treatment with a 1000-Hz modulated RFF. Dashed lines represent the 
95% confidence interval        83 
Figure 3.21: Micronucleus yield in the prostate cancer cell line, DU145, after treatment with 2 Gy of X-
rays alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency 
field          85 
Figure 3.22: Binucleation index in the prostate cancer cell line, DU145, after treatment with 2 Gy of X-
rays alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency 
field          86 
Figure 3.23: Micronucleus yield in the melanoma cell line, MeWo, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field
           87 
Figure 3.24: Binucleation index in the melanoma cell line, MeWo, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field
           88 
Figure 3.25: Micronucleus yield in the melanoma cell line, Be11, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field
           90 
Figure 3.26: Binucleation index in the melanoma cell line, Be11, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field
           91 
Stellenbosch University https://scholar.sun.ac.za
xix 
 
Figure 3.27: Micronucleus yield in the normal lung fibroblasts, L132, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field
           93 
Figure 3.28: Binucleation index in the normal lung fibroblasts, L132, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field
           94 
Figure 3.29: Plot of modifying factors from micronucleus frequency (MNF) at 2 Gy as a function of 
modifying factors from surviving fraction at 2 Gy for 4 cell lines: (A) combined treatment 
with 100-Hz modulated RFF and (B) combined treatment with 1000-Hz modulated RFF. 
Dashed lines represent the 95% confidence interval     97 
Figure 3.30: Plot of modifying factors from binucleation index (BNI) at 2 Gy of X-rays as a function of 
modifying factors from surviving fraction at 2 Gy for 4 cell lines: (A) combined treatment 
with 100-Hz modulated RFF and (B) combined treatment with 1000-Hz modulated RFF. 
Dashed lines represent the 95% confidence interval     99 
 
 
Stellenbosch University https://scholar.sun.ac.za
xx 
 
LIST OF ABBREVIATIONS 
 
:  linear coefficient of inactivation after X-ray irradiation. 
:  quadratic coefficient of inactivation after X-ray irradiation. 
AEF:  alternating electric fields. 
Bax:  Bcl-2-associated X protein. 
Bcl-2:  B-cell lymphoma-2. 
BNI:    binucleation index. 
c-jun:  protein encoded by the JUN gene in humans. 
CO2:  carbon dioxide. 
?̅?:  mean inactivation dose. 
DMSO: dimethyl sulfoxide. 
DNA:   deoxyribonucleic acid. 
EBV:  Epstein-Barr virus.  
egr-1:  early growth response protein 1. 
EMF:  electromagnetic field. 
Flk-1:  gene encoding VEGF-A receptor. 
Gadd45: growth arrest and DNA-damage-inducible protein. 
HBV:  hepatitis B virus.  
HCV:  hepatitis C virus.  
HHV-8: human herpes virus 8. 
HIV:  human immunodeficiency virus. 
HPVs:  human papillomaviruses.  
HTLV-1: human T-lymphotropic virus-1.  
KDR:  kinase insert domain receptor. 
KRAS:  Kirsten rat sarcoma viral oncogene homolog. 
LQ:  linear-quadratic. 
MCV:  Merkel cell polyomavirus.  
Stellenbosch University https://scholar.sun.ac.za
xxi 
 
MEM:  minimum essential medium. 
MF:  modifying factor. 
MNF:  micronucleus frequency. 
MTT:  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.  
p21:  phosphoprotein 21. 
p53:  phosphoprotein 53. 
PBS:  phosphate buffered saline. 
NAD(P)H: nicotinamide adenine dinucleotide phosphate.  
OD:  optical density. 
 PE:  plating efficiency. 
RFF:  radiofrequency fields.  
ROS:  reactive oxygen species. 
SEM:  standard error of the mean. 
SF:  surviving fraction. 
SF2:  surviving fraction at 2 Gy. 
SF6:  surviving fraction at 6 Gy. 
VEGF:  vascular endothelial growth factor. 
WAF1:  protein encoded by p21. 
  
Stellenbosch University https://scholar.sun.ac.za
1 
 
 
 
 
 
 
 
CHAPTER 1 
 
 
 
 
 
 
 
  
Stellenbosch University https://scholar.sun.ac.za
2 
 
1.1. Introduction and Rationale 
 
Cancer is a major cause of human death worldwide (Bray et al., 2012). Cancer arises 
from normal tissues, based on genetic predisposition, persistent inﬂammation, 
environmental factors, life style, and ageing (Katoh and Katoh, 2006). These are the 
factors that can be manipulated and controlled to prevent cancer. Once someone has 
developed cancer, the cancer cells acquire malignant cell behaviour which may 
include loss of the ability to regulate proliferation, resistance to apoptosis, senescence, 
and metastasis, to name a few (Hanahan and Weinberg, 2000; Katoh and Katoh, 
2006). The characteristics exhibited by cancer cells are important factors that must be 
considered when developing effective treatment regimens for cancer (Katoh and 
Katoh, 2006). An effective treatment regimen is one that can overcome or counteract 
the factors that prolong the lifespan of cancer cells. 
 
It is very challenging to treat cancer as cancer cells are continuously changing, and 
becoming resistant to treatment (Carmeliet and Jain, 2011). Many treatment options 
also have a toxic effect on normal cells resulting in patients suffering adverse side-
effects (Mundy et al., 2003). Different cancers respond differently to different types of 
treatment. Some of the options used to treat cancer are surgery, chemotherapy, 
biological therapy and radiation therapy. Surgery is invasive and may leave patients 
disfigured. Also, some cancer cells may be missed and can develop into another 
tumour, leading to emotional stress (Kirova et al., 1998; Donato et al., 2013). 
Chemotherapy, radiation therapy and biological therapy can exert negative effects on 
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patients, as they can be very toxic to normal cells, with some patients dying from the 
side-effects caused by the treatment, and not from the cancer.   
 
Another challenge is the co-morbidity of cancer with other infections making it more 
difficult to manage. Several viruses, such as, human immunodeficiency virus (HIV), 
human papillomaviruses (HPVs), Epstein-Barr virus (EBV), hepatitis B virus (HBV), 
hepatitis C virus (HCV), human herpes virus 8 (HHV-8), human T-lymphotropic virus-
1 (HTLV-1), and Merkel cell polyomavirus (MCV), are linked with cancer in humans 
(Parkin, 2006). These infections weaken the immune system, with radiation therapy 
and other treatment options further weakening the already compromised immune 
system. The co-morbidity of cancer and other infections calls for a need to develop 
non-invasive methods to increase the sensitivity of cancer cells to therapy. 
 
 Radiation therapy is one of the most commonly used treatment options for various 
cancers, however, different tumours respond differently to different radiation doses. 
Melanoma, sarcoma and prostate cancer are examples of cancers that have a lower 
α/β ratio, making them more resistant to lower radiation doses, but sensitive to higher 
doses of radiation (Hegemann et al., 2014). High radiation doses pose a greater risk 
of normal tissue toxicity and a risk of developing severe side-effects. Examples of such 
severe effects are shown in Figures 1.1 and 1.2. 
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Figure 1.1: Radiotherapy-induced skin burns on a patient treated for carcinoma of the base of the 
tongue (from Lee et al., 2002).  
 
 
 
 
Figure 1.2: Radiotherapy-induced late effects and ulceration (from Jacobson et al., 2017). 
 
Considering the mentioned cancer treatment challenges there is a need to find 
regimens that eliminate cancers with minimal invasion and reduced normal tissue 
toxicity or side-effects. Radiofrequency waves are a possible candidate, in 
combination with radiation, to sensitise tumour cells to therapeutic doses of radiation. 
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For decades, electromagnetic fields (EMF) have been shown to exhibit diverse 
biological effects and therapeutic potential on their own or in combination with other 
treatment modalities (Simkó et al., 1998; Tofani et al., 2001; Czyz et al., 2004; Sarimov 
et al., 2005; Crocetti et al., 2013; Tofani, 2015; Lucia et al., 2016; Restrepo et al., 
2016; Solek et al., 2017). The importance of radiation modifiers in radiotherapy, 
radiation protection, and biological dosimetry cannot be overemphasised. Therapeutic 
benefit has been demonstrated for the use of electromagnetic fields in cancer patients, 
where EMF treatment resulted in reduced disease progression, prolonged patient 
survival, and no significant side-effects (Kirson et al., 2007; Barbault et al., 2009; 
Verginadis et al., 2012). In fact, significant evidence exists suggesting that 
electromagnetic fields could potentially be the future of non-invasive and non-toxic 
therapy (Vadalà et al., 2016). 
 
 Although the mechanisms by which EMF interact with cells are not well understood, 
many studies have shown that electromagnetic fields of a wide range of frequencies 
can influence multiple cellular processes, such as cell proliferation, differentiation, cell 
cycle, apoptosis, DNA replication, production of reactive oxygen species, and 
protein/gene expression (Simkó et al., 1998; Tofani et al., 2001; Czyz et al., 2004; 
Sarimov et al., 2005; Crocetti et al., 2013; Tofani, 2015; Lucia et al., 2016; Restrepo 
et al., 2016; Solek et al., 2017). The multiplicity of effects of EMF extends to their 
capacity to stimulate the immune system (Walleczek, 1992), which may in turn 
mediate cellular responses to therapeutic interventions. Additionally, it has been 
suggested that some EMF, especially at high frequencies, can disrupt nervous system 
function and result in neurodegenerative disorders like autism (Ahuja et al., 2013), 
while others of lower frequencies stimulate damaged tissue recovery (Palti, 1966; 
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Bassett et al., 1981; Bassett, 1985; Polk, 1995; Markov and Colbert, 2001; Harden et 
al., 2007).  
 
Although it was suggested two decades ago that EMF can enhance the effects of 
ionising radiation (Miyakoshi et al., 1999; Ding et al., 2000; Artacho-Cordón et al., 2013 
for review), there is still a paucity of studies on the combined biological effects of EMF 
and ionising radiation. In a recent study by our group, no cytotoxic effects were 
observed in fibroblasts and melanoma cells, when cells were exposed to 27.125 MHz 
fields that were amplitude-modulated at 100 or 1000 Hz alone (Chinhengo et al., 
2018). However, it was demonstrated that electromagnetic fields have the desirable 
radiosensitising and radioprotective effects on tumour (melanoma) and normal 
(fibroblasts) cells, respectively (Chinhengo et al., 2018). It was further shown that EMF 
may significantly reduce the total radiation dose during radiotherapy and minimise 
normal tissue toxicity without compromising on tumour control (Chinhengo et al., 
2019). The diversity of effects, or lack thereof, is likely due to the wide range of 
frequencies, types of electromagnetic fields (electric, magnetic, or radio), and cellular 
systems used.  
 
Given that radiofrequency waves show potential to act as radiosensitisers and 
radioprotectors, there is a need to understand the mechanisms underlying their 
modulatory effects. This may assist in designing patient- and tumour-specific 
therapeutic approaches that can lead to more effective cancer management.   
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1.2. Literature Review 
 
1.2.1. Radiation Therapy Overview 
 
Radiation therapy is one of the widely used cancer treatment options in the world 
(Liauw et al., 2013; Guadagnolo et al., 2013; Perez and Mutic, 2013; Hur and Yoon, 
2017). Radiation induces cell death by direct or indirect damage to the DNA as 
illustrated in Figure 1.3. When radiation interacts with DNA, it causes single strand 
and double strand breaks. These breaks, if not efficiently repaired, obstruct the ability 
of the cells to divide and proliferate further. Double strand breaks are more responsible 
for cell death than the single strand breaks, as they are more difficult to repair (Jackson 
and Bartek, 2009; Baskar et al., 2012).  
 
                   Direct action                                        Indirect action 
 
Figure 1.3: Radiation interacts with cellular DNA directly or indirectly (adapted from Basker et al., 2012). 
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Cells affected by radiation may die via various means, including apoptosis and 
necrosis. Ionising radiation also damages the cell membrane triggering pathways that 
are important in apoptosis and may lead to cell death, as illustrated in Figure 1.4 
(Cohen-Jonathan et al., 1999). 
 
Figure 1.4: Radiation damage triggers a signal that is relayed from ATM to p53, leading to cell death 
(adapted from Cohen-Jonathan et al., 1999). 
 
The dying tumour cells may also aid in tumour control by releasing cellular signals that 
boost antitumour immunity. A phenomenon called the bystander effect has been 
reported where dying irradiated tumour cells release signals that trigger neighbouring 
unirradiated tumour cells to die (Hur and Yoon, 2017; Peng et al., 2017). Radiation 
therapy does not only kill cancer cells, but also activates the immune system against 
future proliferation of cancer cells. This immune response is, however, limited and may 
not be able to completely control tumours.  
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The delivery of radiation therapy has improved significantly over time in terms of 
normal tissue sparing, but there is still damage to healthy tissue surrounding the 
tumour, with resultant adverse side-effects in patients. Radiotherapy can be delivered 
to patients in several small doses over the course of several weeks 
(hyperfractionation), or in large doses given over a shorter space of time 
(hypofractionation). In light of reported findings that exposure of cells to low radiation 
doses may blunt the p53 response, leading to a radioadaptive response (Takahashi, 
2002), it may be prudent to use hypofractionated radiation therapy to effectively kill 
tumour cells without inducing a radioresistant response (Barlow et al., 2016). In vitro, 
hypofractionation treatment has been found to be more effective at killing tumour cells, 
leading to a delay in tumour outgrowth and improved cell survival rates, when 
compared to hyperfractionation. Hypofractionation may, therefore, be more beneficial 
in tumour control (Barlow et al., 2016).  
 
Hypofractionated external beam radiotherapy has gained increasing popularity for 
cancers that have a lower α/β ratio, and are thus relatively more resistant to lower 
radiation doses but more sensitive to higher doses. For example, the treatment of 
melanoma, sarcoma, and prostate cancer is better when fractional radiation doses 
higher than the conventional 2-Gy are used. There are advantages to using 
hypofractionation over hyperfractionation, such as saving on treatment time and 
medical resources, making it more convenient for the patients (Hegemann et al., 
2014). Hypofractionated radiation therapy is given over a shorter period than standard 
radiation therapy. It is becoming the standard of care for lung, breast, and prostate 
cancer patients. The main challenge of hypofractionation is normal tissue toxicity, 
which can be overcome if a modifying agent is used in combination with radiation. The 
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best modifying agent is one that sensitises the tumour whilst protecting the normal 
tissue. EMF have been found to sensitise cancer cells to radiation whilst protecting 
normal cells (Sylver, 2009; Crocetti et al., 2013; Chinhengo et al., 2018, 2019), 
suggesting that EMF can be a useful option as a radiomodulator in hypofractionated 
radiotherapy; and in hyperfractionated radiotherapy to sensitise cancer cells and 
possibly prevent a radioadaptive response. 
 
1.2.2. Targeted Therapy 
 
Targeted therapy is a cancer treatment that targets the cancer’s specific genes, 
proteins, or the tissue environment that contributes to cancer growth and survival. 
Targeted therapy is designed to attack defects found in cancer cells but not in normal 
cells. There are several types of targeted therapy e.g. Monoclonal antibodies, which 
send toxic substances directly to cancer cells, and small-molecule drugs, which block 
the process that helps cancer cells multiply and spread e.g. angiogenesis inhibitors. 
The mode of action for targeted therapy drugs is to block or turn off signals that tell 
cancer cells to grow and divide, thus keeping cells from living longer than normal. The 
same targeted treatment will not work for all tumours, since not all tumours have the 
same targets. It is important to know the status of the targeted gene in order to use 
targeted therapy effectively e.g. cetuximab which targets KRAS will not be effective in 
treating a cancer with a defective KRAS gene (Nakadate et al., 2014) 
 
Czyz and colleagues observed an upregulation of c-jun, p21 and egr-1 mRNA levels 
in p53-deficient cells, but not in p53 wild-type cells, when cells were exposed to a 1.71 
GHz field (Czyz et al., 2004). C-jun and p21 regulate cell cycle progression. EMF 
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exposure has been shown to increase the expression levels of the VEGF receptor, 
KDR/Flk-1, in normal human umbilical vein endothelial cells (Delle Monache et al., 
2008). Therapeutic targeting of VEGF has been tested and show positive results (Rini 
and Small, 2005). Since EMF cause upregulation and downregulation of certain genes 
and proteins they can be used to strategically upregulate or downregulate genes that 
control survival pathways in cancer cells. With further investigation, EMF can be useful 
in targeted therapy. 
 
1.2.3. Combination Therapy 
  
Combination therapy is a treatment option that combines two or more therapeutic 
agents (Mokhtari et al., 2017). Different treatment agents affect cancer cells at different 
stages of the cell cycle thus using more than one agent means more cells in the 
population are targeted, increasing the chances of eliminating cancer cells. Since the 
1970’s, combination chemotherapy has been used, but, the use of more than one drug 
at a time poses a risk of drug interactions which may negatively affect the patient. 
Combination chemotherapy may be effective with some cancers whilst single drug 
chemotherapy works better with other cancers. Combination therapy is advantageous 
in that it decreases the chance of a tumour developing resistance, for it addresses 
several targets at the same time, and since tumour cells vary from each other in 
heterogeneity, some cells may respond to one treatment agent whilst some respond 
to the other, and this may lead to the use of lower doses of drug or radiation.  
 
The effectiveness of radiation therapy is influenced by many factors, such as the 
position of tumour, tumour progression and the size of the tumour. Other factors and/or 
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substances have been found to influence radiation therapy and so have been 
employed in combination therapy to further sensitise cancer cells to radiation. Some 
substances have been found to protect normal cells against the effects of radiation 
whilst making the tumour cells more sensitive to the same radiation dose. 
 
Most cancers have defective housekeeping and tumour suppressor genes, such as, 
those encoding the heat shock protein 90 (Hsp90) and p53. These genes, when 
unaltered or not inactivated, are required for the maintenance of basic cellular function, 
and are expressed in all cells of an organism under normal and patho-physiological 
conditions (Levine et al., 1991; Barrot and Haystead, 2013). A defective p53 gene in 
cancer cells (e.g. the melanoma cell line, MeWo) may allow cells to proliferate, even 
after they have sustained radiation damage. Thus, there is a need to use substances, 
in combination with radiation, that may activate genes downstream of the defective 
gene so that the damaged cells can be forced to stop proliferating, through apoptosis 
or other gene-regulated means. A good agent to use in combination with radiation is 
one that influences the biochemical processes and gene expressions triggered by 
radiation, leading to improved tumour control. Recent work has shown that extremely 
low frequency electromagnetic fields can significantly enhance the cytotoxic effects of 
temozolomide, a widely-used chemotherapeutic agent, in glioblastoma cells 
(Akbarnejad et al., 2017). 
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1.2.4. The Co-morbidity of Cancer and Other Infections, and the Possible 
Influence of EMF on the Management of Such Cancers 
 
Studies have demonstrated that infectious pathogens are associated with up to one-
sixth of cancers worldwide (Parkin, 2006; de Martel et al., 2012). Infections with certain 
viruses, bacteria, and parasites are strong risk factors for specific cancers. 
 
The co-morbidity of cancer with other infections makes it more difficult to manage. 
Several viruses, such as, human immunodeficiency virus (HIV), human 
papillomaviruses (HPVs), Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis 
C virus (HCV), human herpes virus 8 (HHV-8), human T-lymphotropic virus-1 (HTLV-
1), and Merkel cell polyomavirus (MCV), are linked with cancer in humans (Parkin, 
2006). Examples of HHV-8 associated Kaposi’s sarcoma and HPV-mediated genital 
warts associated with cervical cancer are illustrated in Figures 1.5 and 1.6, 
respectively.  
 
 
Figure 1.5: HHV-8 associated Kaposi’s Sarcoma (National Cancer Institute visuals online, 2001; 
https://visualsonline.cancer.gov/details.cfm?imageid=2168 ). 
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Figure 1.6: HPV-mediated genital warts associated with cervical cancer (Feigwarzen Bilder; 
https://www.warzen-hilfe.com/feigwarzen-welcher-arzt/) 
 
These infections weaken the immune system, and radiation therapy further weakens 
the already compromised immune system. The co-morbidity of cancer and other 
infections calls for a need to develop non-invasive methods to sensitise cancer cells 
to therapeutic treatment doses. The best treatment options would be ones that target 
the cancer cells and the associated bacteria, viruses or parasites.  
 
Electromagnetic fields (EMF) have been reported to activate the immune system and 
sensitise cancer cells to radiation, so they may be used in combination with radiation 
to improve treatment of cancers associated with other infections. Inhan-Garip and 
colleagues found that EMF induce a decreased growth rate in some bacteria (Inhan-
Garip et al., 2011) and its use in combination with radiation may, therefore, be useful 
in treating cancers associated with other infections. Exposure of oncogenic viruses to 
extremely low frequency electromagnetic fields has been shown to lead to defective 
viral progeny (Pica et al., 2006). 
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The association of cancer with other infections makes it more challenging to treat 
effectively as other infections further weaken the immune system and sometimes 
intensify the side-effects posed by radiation therapy. There is, therefore, the need to 
find agents that can sensitise the cancer cells to radiation whilst protecting normal 
tissue, thus improving tumour control without further compromising the normal tissue. 
EMF may be a good modifying agent to use in combination with radiation for the 
treatment of cancers associated with other infections.  
 
1.2.5. Effects of Electromagnetic Fields  
 
For over half a century, there has been a growing interest in the investigation of 
extremely low, through medium, to high frequency electromagnetic fields for their 
potential application in the clinic. These fields may be classified as non-thermal non-
ionising radiation, present as magnetic, electric, or radiofrequency waves, and have 
been shown to exhibit a wide range of effects in biological systems. The extent of the 
attributes of electromagnetic fields has led to suggestions that they have a high 
potential of becoming the future of holistic medicine, with the capacity of curing cancer 
and other ailments (Sylver, 2009; Purnell and Whitt, 2016). 
 
1.2.5.1. Electric Fields 
 
Alternating electric fields (AEF) have shown a wide range of effects on living tissues, 
in a frequency-dependent manner. At very low frequencies (under 1 kHz), AEF can 
stimulate excitable tissues and have been used for nerve, muscle, and heart 
stimulation to promote regeneration (Palti, 1966; Polk, 1995; Markov and Colbert, 
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2001). Electric fields also stimulate osteoblast proliferation and could enhance the 
efficacy of orthopaedic implants (Ercan and Webster, 2008).  
 
Although several non-thermal cellular effects of AEF have been observed 
(Zimmerman et al., 1981; Holzapfel et al., 1982; Pawlowski et al., 1993), a number of 
in vitro and in vivo studies have illustrated the antiproliferative and anticancer effects 
of alternating electric fields (Kirson et al., 2004; Kirson et al., 2007). These interesting 
results led to the implementation of such approaches in humans, and initial results on 
a number of tumour entities/sites were encouraging (Kirson et al., 2007; Salzberg et 
al., 2008). 
 
Furthermore, studies involving low-intensity, intermediate frequency (100-300 kHz) 
alternating electric fields have clearly documented that these antiproliferative effects 
are mediated by processes like cell cycle arrest and mitotic disruption (Gera et al., 
2015; Giladi et al., 2015). A significant level of evidence exists of therapeutic 
responses in patients with cancer, demonstrating that electric field treatment results in 
a retardation of disease progression and extended patient survival, with little or no 
obvious side-effects (Kirson et al., 2007; Verginadis et al., 2012; Davies et al., 2013; 
Mrugala et al., 2017; Benson, 2018; Burri et al., 2018; Magouliotis et al., 2018).  
 
Electric fields have been extensively shown to enhance the therapeutic efficacy of 
other treatment modalities. Mild electrical stimulation, when combined with 
hyperthermia, has been reported to reduce insulin resistance and enhance fat 
metabolism in diabetic mice (Morino et al., 2008). A strong synergy in colorectal cancer 
cell killing in a mouse xenograft model was demonstrated, when tumours were treated 
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with an electric field and hyperthermia (Andocs et al., 2009).  Electric field treatment 
enhances the cytotoxic effects of a number of chemotherapy drugs in in vitro cell 
cultures, animal tumour models (e.g. recurrent glioblastoma multiforme, hepatocellular 
carcinomas, breast carcinomas), and clinical trials (Janigro et al., 2006; Kirson et al., 
2007; Salzberg et al., 2008; Kirson et al., 2009a). O’Connell and colleagues 
demonstrated the capacity of combined electric field and bevacizumab treatment to 
significantly stabilise grade IV astrocytoma in a paediatric patient (O’Connell et al., 
2017). Kesari and colleagues also reported a prolonged overall survival in 
glioblastoma patients when they were treated with a combination of electric fields and 
temozolomide after a first recurrence (Kesari et al., 2017).  An extension of overall 
survival of more than seven years has been documented for patients with primary and 
recurrent glioblastoma multiforme who received electric field therapy (Rulseh et al., 
2012). Several other studies have demonstrated the efficacy of electric fields, 
administered alone or in combination with chemotherapy drugs, to inactivate cancer 
cells, improve tumour control, prolong patient survival, and maintain quality of life 
(Schneiderman et al., 2010; Stupp et al., 2012, 2015, 2017; Vergote et al., 2018; Toms 
et al., 2019).   
 
In addition to preventing tumour growth, electric fields have been shown to inhibit 
tumour cell migration, invasion, and metastasis (Kirson et al., 2009b; Kim et al., 2016). 
They also exhibit antimicrobial effects (Giladi et al., 2008, 2010; Gabi et al., 2011; 
Freebairn et al., 2013; Shawki and Gaballah, 2015), and may be an effective modality 
for treating infections. Currently, application of electric fields in the clinical setting is 
expanding, especially in the domain of cancers of the central nervous system. 
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1.2.5.2. Magnetic Fields 
 
Low-frequency pulsed magnetic fields have also shown a markedly wide range of 
effects in biologic systems, and have been useful in clinical applications. These fields 
have been known to stimulate various tissues to enhance repair, as in the cases of 
increased bone and cartilage growth, accelerate fracture healing, and relief of low back 
pain; and have even been used to treat depression (Bassett et al., 1981; Bassett, 
1985; Markov and Colbert, 2001; Harden et al., 2007; Parate et al., 2017; Madduri et 
al., 2018). Magnetic fields have also been used to successfully treat wounds (Cheing 
et al., 2014; Haghnegahdar et al., 2014; Cañedo-Dorantes et al., 2015; Zahedi and 
Yadollahpour, 2016; Madduri et al., 2018; Kwan et al., 2019). The mechanisms 
underlying the efficacy of magnetic fields in improving wound healing include 
enhanced fibroblast polarisation and migration (Purnell and Skrinjar, 2016), increased 
deposition of collagen fibre (Choi et al., 2016), and stimulation of cell proliferation 
(Cheng et al., 2017). Magnetic field treatment has also been found to enhance nerve 
regeneration (Beck-Broichsitter et al., 2014), postnatal neovascularisation (Li et al., 
2015), and human erythrocyte health (Purnell et al., 2018a). The benefit of magnetic 
fields in restoring cardiac function has also been documented (Hao et al., 2014; Ma et 
al., 2016).  
 
Low level electromagnetic energies, akin to those of magnetic fields, exert negative 
influences on cancer cells, but not their normal counterparts (Crocetti et al., 2013; 
Purnell et al., 2018b; Purnell, 2019). The antitumour effects of magnetic fields have 
been extensively demonstrated in a number of tumour entities/sites (Ronchetto et al., 
2004; Verginadis et al., 2012; Sengupta and Balla, 2018). These fields have long been 
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known to stimulate the activity of immune cells (Walleczek, 1992; Baranowska et al., 
2018; Rosado et al., 2018; Mahaki et al., 2019), which may subsequently enhance 
antitumour immunity in cancer patients.  
 
A growing number of studies have attributed the anti-proliferative effects of magnetic 
fields on cancer cell changes in metabolic activity, differentiation, cell cycle 
progression, and the profiles of apoptosis, DNA replication, production of reactive 
oxygen species, and protein/gene expression (Lai and Singh, 1997; Simkó et al., 1998; 
Tofani et al., 2001; Sarimov et al., 2005; Morabito et al., 2010; Kovacic and 
Somanathan, 2010; Crocetti et al., 2013; Tofani, 2015; Lucia et al., 2016; Restrepo et 
al., 2016; Solek et al., 2017; Novoselova et al., 2019). Magnetic fields have been 
shown to cause G1 phase arrest by activating the ATM-ChK2-p21 pathway (Huang et 
al., 2014). Solek and colleagues also found that magnetic fields can induce the 
p53/p21-mediated apoptotic signalling pathway and cell cycle arrest in mouse 
spermatogenic cells in vitro, and concluded that these fields may affect fertility (Solek 
et al., 2017).  
 
In addition, chemotherapy drug cytotoxicity enhancing effects of magnetic fields have 
been widely demonstrated in cell cultures, in in vivo models, and patients (Salvatore 
et al., 2003; Baharara et al., 2016; Sengupta and Balla, 2018). Although there has 
been a growing interest in research involving electromagnetic fields, only a handful of 
studies have reported of the biological effects of magnetic fields with ionising radiation 
(Miyakoshi et al., 1999; Ding et al., 2000; Artacho-Cordón et al., 2013).  
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1.2.5.3. Radiofrequency Fields 
 
The biological effects of radiofrequency fields are varied, and may be categorised as 
genotoxic (e.g. chromosomal aberration, micronucleus formation) and non-genotoxic 
(e.g. gene expression, cell proliferation, reactive oxygen species) (Miyakoshi, 2013). 
For medical and research purposes, radiofrequencies are generated by amplitude 
modulating a carrier frequency of ~27.12 MHz. The antitumour effects of 
radiofrequency fields (RFF) have been attributed to a unique phenomenon of the 
existence of tumour-specific modulating frequencies, whereby fields modulated by 
certain frequencies only exert their effects on particular tumours (Elson, 1995; 
Zimmerman et al., 2013; Jimenez et al., 2018). Radiofrequency tumour ablation, 
mediated by this phenomenon, is correlated with the dielectric property of the tumour 
in question and, thus, its water content (Chou, 1995; 2007). Treatment of patients with 
advanced hepatocellular carcinoma with modulating frequencies ranging from 100 Hz 
to 21 kHz yielded positive results (Costa et al., 2011). Barbault and colleagues treated 
163 patients for 15 cancers with modulating frequencies of 100 Hz – 114 kHz and 
noted that the most common specific frequencies for breast cancer, hepatocellular 
carcinoma, prostate cancer and pancreatic cancer were 1873.477 Hz, 2221.323 Hz, 
6350.333 Hz, and 10456.383 Hz, respectively (Barbault et al., 2009). Frequency-
dependent antiproliferative effects were also demonstrated in hepatocellular 
carcinoma and breast cancer cells, but not in normal cells (Zimmerman et al., 2012).  
 
The selectivity of radiofrequencies in negatively affecting only malignant cells could be 
harnessed for more effective cancer management. However, unlike for electric and 
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magnetic fields, studies investigating the combined effects of radiofrequency fields and 
chemotherapeutic drugs or ionising radiation are virtually non-existent.  
 
A couple of studies performed by our group, using fibroblasts and melanoma cells 
show that electromagnetic fields can act either as radiosensitisers or radioprotectors 
(Chinhengo et al., 2018; 2019). An insight into the factors that influence these 
modifying effects could have significant implications in radiotherapy and radiation 
protection settings. 
 
DNA damage by ionising radiation induces the gene expression of p53-target 
molecules, involving WAF1, Gadd45, Bax and p53.  Most tumour cells, however, have 
a mutant or defective p53 gene and this could allow abnormal and damaged cells to 
proliferate. Other genes downstream of p53 can be manipulated to regulate the cell 
cycle and suppress tumour progression. Czyz and colleagues found that the exposure 
of p53 deficient cells to high frequency radio waves (1.71 GHz) induced an 
upregulation of egr-1 (an early growth response gene), a phenomenon not seen in p53 
wild-type cells, and suggested that loss of p53 function may affect the sensitivity of 
cells to radiofrequency exposure (Czyz et al., 2004). It is, therefore, possible that p53 
status plays a key role in the manner by which radiofrequencies modulate cellular 
response to ionising radiation. 
 
Radiofrequency fields may cause an increase in endogenous cellular factors that 
result in elevated levels of reactive oxygen species (ROS) and DNA damage (Phillips 
et al., 2009). This may be due to increased mitochondrial membrane permeability, 
pore formation, and increased nicotinamide adenine dinucleotide phosphate 
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(NAD(P)H) content (Dumas et al., 2009). An increase in NAD(P)H may lead to an 
increase in the formation of ROS, which is mediated by NAD(P)H oxidase. NAD(P)H 
oxidase reduces oxygen to the reactive oxygen species, oxygen radical and hydrogen 
peroxide. The primary and sole function of NAD(P)H oxidase is ROS production, so 
the absence of NAD(P)H prevents formation of reactive oxygen species (Raza et al., 
2017). NAD(P)H is a coenzyme for many enzymes in the cell. Other functions of 
NAD(P)H include the detoxification of xenobiotics, participation in amino acid 
metabolism, as a requirement in immune functions, like phagocytosis, and synthesis 
of fatty acids. Therefore, a depletion of NAD(P)H may prevent the proper functioning 
of cells.  
 
To maintain ROS homeostasis and avoid cell death, cancer cells increase their 
antioxidant capacity. This altered redox environment of cancer cells, compared with 
normal cells, may increase their susceptibility to ROS-manipulation therapies (Reczek 
and Chandel, 2017). Cancer cells require a certain level of ROS, above or below which 
cell death is induced or promoted. This biochemical difference between cancer and 
normal cells can be exploited to develop and employ therapeutic agents to 
preferentially target cancer cells (Raza et al., 2017). It would, therefore, be interesting 
to interrogate the role of reactive oxygen species in mediating radiomodulatory effects 
of radiofrequency fields. 
 
Iron content in cells determines the production of free radicals. As cancer cells have 
higher iron content, they should be expected to be more responsive than normal cells 
to magnetic fields induced by radiofrequency fields. The action of induced magnetic 
fields in cells is mediated by the Femton effect, as demonstrated in Figure 1.7. 
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Figure 1.7: The Fenton reaction: conversion of hydrogen peroxide (H2O2) into a highly reactive hydroxyl 
radical (OH) in the presence of iron (Phillips et al., 2008). 
 
Taking the abovementioned diverse effects of EMF into account, it can be reasoned 
that EMF would play a key role in the manner by which ionising radiation affects 
biological systems. The main objectives of this study were to: (1) further interrogate 
the finding that low-medium radiofrequency waves can act both as radiosensitisers 
and radioprotectors (Chinhengo et al., 2018, 2019), and (2) identify potential 
mechanisms underlying such phenomena, using an expanded panel of established 
cancer and normal cell lines. It is anticipated that the findings of this study will form the 
basis for future studies on human specimens, such as peripheral blood lymphocytes, 
especially if they can be extrapolated to doses of relevance to radiation protection and 
biological dosimetry. The study should contribute significantly toward a more reliable 
interpretation of the relationship between radiation absorbed dose and effect, as well 
as, inform practitioners in radiotherapy, radiation and environmental protection, 
occupational health, and biological dosimetry on delivery of more efficient services.  
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1.3. Problem Statement 
 
There are many challenges encountered in cancer therapy, the major ones being 
resistance to treatment and normal tissue toxicity. Melanoma, sarcoma and prostate 
cancer are some of the superficial cancers that have a lower α/β ratio. These cancers 
are best treated using hypofractionation (i.e. higher fractional doses of radiation), as 
they do not respond well to low doses per fraction. Hypofractionation, however, leads 
to high normal tissue toxicity which the patient may not easily recover from. There is 
an urgent need to develop non-invasive methods, to further sensitise cancer cells (or 
tumours) to therapeutic doses of ionising radiation. Such procedures may induce 
radioprotection to the normal tissue while further sensitising the tumour to radiation, 
thus achieving better tumour control and reducing toxicity to normal tissue. On the 
other hand, interpretation of the effects of low doses of radiation can be complicated 
by interaction between ionising radiation and ambient factors, such as those involved 
when employing potentially non-invasive approaches with the aim of sensitising 
cancer cells. Identifying mechanisms underlying such interactions would have 
significant ramifications for radiation risk assessment (radiation protection).   
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1.4. Research Question 
 
Do radiofrequency electromagnetic waves modulate the radiosensitivity of cancer and 
normal cells in vitro? If so, are there identifiable mechanisms that mediate such 
modulatory effects?  
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1.5.  Hypothesis 
 
It is hypothesised that in vitro exposure of cancer cells to radiofrequency 
electromagnetic waves can preferentially increase their radiosensitivity; and that this 
phenomenon is mediated by modifications in identifiable cellular features. 
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1.6. Aims and Objectives 
 
This study aimed to assess the potential therapeutic benefit of combining 
radiofrequency fields (RFF) with radiation therapy in an in vitro setting and to identify 
factors mediating such benefits, using human lung fibroblasts, prostate cancer cells, 
and melanoma cells. 
 
To achieve these specific aims, the specific study objectives are as follows: 
 
1. To identify the radiofrequency and X-ray combinations that significantly 
increase the radiosensitivity of melanoma and prostate cancer cells, relative to 
normal lung fibroblasts.  
2. To monitor superoxide dismutase (SOD) activity following exposure to 
radiofrequency waves and X-rays, in order to evaluate how oxidative stress is 
involved in the modulation of radiosensitivity by RFF. 
3. To evaluate the effect of combined RFF and X-ray exposure on metabolic 
activity, in order to determine how changes in metabolic activity are related to 
the radiomodulatory effects of radiofrequency waves. 
4. To evaluate the effect of RFF exposure on DNA damage responses, based on 
micronucleus yield.  
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1.7. Delineations 
 
This study used the PERL M+ oscillator amplifier (Resonant Light Technology, 
Courtenay, Canada; Serial #: PM 171116) to produce 27.125 MHz fields, square-wave 
amplitude-modulated at 100, 1000, 2000 or 4000 Hz, to evaluate the effect of 
radiofrequency fields in cell cultures. The resulting radiofrequencies were broadcast 
via an argon plasma ray tube, acting as an antenna, onto the cells. Four cell lines were 
used in this study: a p53 mutant melanoma cell line, MeWo; a p53 wild-type melanoma 
cell line, Be11; a p53 mutant prostate cancer cell line, DU145; and a p53 wild-type 
normal lung fibroblast cell line, L132. 
 
The research variables determined in this study were intrinsic cellular radiosensitivity, 
the radiomodulatory effects of radiofrequency fields and treatment-induced changes 
in metabolic activity, reactive oxygen species formation, and DNA damage and repair. 
The colony forming assay was used to determine intrinsic radiosensitivity and 
radiomodulation by means of radiofrequency fields. The 3-(4, 5-dimethylthiazol-2-yl)-
2, 5 diphenyltetrazolium bromide (MTT) assay was used to measure treatment-
induced changes in metabolic activity. The micronucleus assay was used to measure 
the effect of treatment on DNA damage and repair. The SOD assay was used as a 
measure of ROS levels. Modifying factors were derived from all the assays to 
determine how the cells responded to the treatment. These research variables were 
deemed enough to prove the research hypothesis. 
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1.8. Limitations 
 
 The melanoma and prostate cancer cell lines were compared to a normal lung 
cell line instead of corresponding normal prostate and skin cell lines for true 
representation. 
 Due to financial constraints, the SOD assay was only performed using one 
frequency of radiofrequency fields. 
 The effect of treatment on protein and / or gene expression was not performed 
due to time and financial constraints. 
 
Two of the cell lines (DU145 and MeWo) were derived from metastatic lesions, and it 
has been shown that metastatic cancer has increased mutation burden compared to 
primary cancer, and that immune related gene expression is higher in metastatic 
cancer cell lines than in cell lines derived from non-metastatic cancer (Liu et al., 2019). 
A metastatic cell line may not be a true representative of the primary tumour. 
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CHAPTER 2 
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2. Materials and Methods 
 
2.1. Study Location and Ethical Consideration 
All experiments were performed in the Division of Radiobiology, Faculty of Medicine 
and Health Sciences, Stellenbosch University, Tygerberg. The study was approved by 
the Health Research Ethics Committee (HREC) of the Faculty of Medicine and Health 
Sciences, Stellenbosch University, South Africa (HREC Reference #: S17/10/207; 
Appendices A & B). 
 
2.2. Cell Lines and Culture Maintenance  
Four cell lines (2 melanoma, 1 prostate cancer, 1 lung fibroblast; 2 p53 mutant, 2 p53 
wild-type) were used in this study and are detailed below: 
 
MeWo 
The MeWo cell line (ATCC® Number: HTB-65™) is a p53 mutant, adherent, human 
malignant melanoma cell line derived from a metastatic lymph node, and was kindly 
provided by Profs F. Zölzer and C. Streffer (University of Essen, Germany). The cells 
were routinely cultivated as monolayers in 75 cm2 flasks in minimum essential medium 
(MEM), supplemented with 20% foetal bovine serum (FBS) and 1% penicillin-
streptomycin, and incubated at 37°C in a humidified atmosphere (95% air, 5% CO2). 
Cells were used for experiments upon reaching 80-90% confluence (passage 
numbers: 17-25). 
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Be11 
The BE11 cell line is a p53 wild-type, human melanoma cell line, and was also kindly 
provided by Profs F. Zölzer and C. Streffer (University of Essen, Germany). The cells 
were routinely cultivated as monolayers in 75 cm2 flasks in MEM, supplemented with 
10% FBS and 1% penicillin-streptomycin, and incubated at 37°C in a humidified 
atmosphere (95% air, 5% CO2). Cells were used for experiments upon reaching 80-
90% confluence (passage numbers: 12-21). 
 
DU145 
The human prostate cancer cell line, DU145 (ATCC® Number: HTB-81D™), is a p53 
mutant, adherent cell line derived from a metastatic lesion of the central nervous 
system (Stone et al., 1978), and was a gift from Prof P. Bouic (Synexa Life Sciences, 
Montague Gardens, South Africa). The cells were also cultivated as monolayers in 75 
cm2 flasks in MEM, supplemented with 10% FBS and 1% penicillin-streptomycin, and 
incubated at 37°C in a humidified atmosphere (95% air, 5% CO2). Cells were used for 
experiments upon reaching 80-90% confluence (passage numbers: 16-18). 
 
L132 
The human normal lung epithelial cell line, L132 (ATCC® Number: CCL-5™), is a p53 
wild-type cell line, and was a gift from Dr T. Robson (University of Ulster, UK). L132 
was used to represent normal tissue. The cells were routinely cultivated as monolayers 
in 75 cm2 flasks in Roswell Park Memorial Institute medium (RPMI) supplemented with 
10% FBS and 1% penicillin-streptomycin, and incubated at 37°C in a humidified 
atmosphere (95% air, 5% CO2). Cells were used for experiments upon reaching 80-
90% confluence (passage numbers: 24-30). 
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2.3. Preparation of Cell Cultures for Experiments  
 
Exponentially growing cell cultures were trypsinised into single-cell suspensions and 
seeded in varying numbers into 25-cm2 tissue culture flasks (for colony and superoxide 
dismutase activity assays), 35-mm plastic petri dishes (for micronucleus assay), or 96-
well cell culture plates (for metabolic activity assay), dependent on the level of 
absorbed radiation dose, cell line, and experiment. The corresponding final volumes 
of culture medium were 10 ml, 2 ml, and 100 µl, respectively. 
 
2.4. Irradiation of Cell Cultures 
 
Appropriately prepared cell cultures were irradiated at room temperature (20°C) to 
doses up to 10 Gy, at a dose rate of 1.0 Gy/min, using a Precision MultiRad 160 X-
irradiator (Precision X-Ray Inc., Branford, CT, USA), as shown in Figure 2.1. Sham-
irradiated cultures (0 Gy) were left on the turntable of the running Precision X-ray 
irradiator for 2 min with the X-ray source turned off and were used as controls. 
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Figure 2.1: Photograph of the Precision MultiRad 160 X-ray irradiator (door opened) showing cell 
culture flasks on the turntable.   
 
2.5. Radiofrequency Generation and Exposure 
 
For cell culture exposure to radiofrequency fields, a PERL M+ oscillator amplifier 
(Resonant Light Technology, Courtenay, Canada; Serial #: PM 171116) was used to 
produce 27.125 MHz fields, square-wave amplitude-modulated at 100, 1000, 2000 or 
4000 Hz, with a peak-to-peak amplitude of 5 V. The modulating frequencies were 
generated, using a ProGen II frequency generator with an output impedance of 50  
and a duty cycle of 50% (Resonant Light Technology, Courtenay, Canada; Serial #: 
PG 171211). The resulting radiofrequencies were then broadcast via an argon plasma 
ray tube (length: 29 cm, diameter: 2.55 cm, pressure: 20 Torr), acting as an antenna, 
onto the cells. For sham-RFF exposure (no radiofrequency field), unirradiated (0 Gy) 
cell cultures were placed under the plasma ray tube when turned off. The set-up is 
shown in Figure 2.2A. A maximum of 16 cell culture flasks, stacked in groups of four, 
could be exposed at a given time. As illustrated in Figure 2.2B, the volume occupied 
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by the cell culture layers had outside dimensions of 11 cm (Width: 2 flasks 
breadthwise) × 18 cm (Length: 2 flasks lengthwise) × 10 cm (Height: 4 flasks by 
height). The perpendicular distances from the axis of the plasma tube to the four cell 
culture planes were 19.0, 21.4, 23.8, and 27.0 cm. Each cell layer was covered with 
10 ml of culture medium (medium depth: 3.5 mm).  
 
Figure 2.2: (A) Photograph of the electromagnetic field (EMF) exposure system, with the PERL M+ 
inverted on an appropriately cut styrofoam box. (B) A 2-dimensional schematic diagram showing the 
top and bottom cell culture planes of the 224 flask matrix. In the set-up, the plasma ray tube is centred 
horizontally above the cell culture flasks, such that the induced magnetic field (B) is parallel to the base 
of a flask and the induced electric field (E) in the culture medium is parallel to the width of the flask.  
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The induced electric fields in the cell cultures were estimated, using a large-loop H-
Field probe (Beehive Electronics, California, USA; cat # 100C) coupled to a digital 
storage oscilloscope (Hantek Electronic Co. Ltd., Qingdao, China; Serial #: 
DSO5062BM). For this, the loop was positioned perpendicularly (in air) to the RF wave 
(Figure 2.2B), at the respective cell culture planes. During sham exposure 
(background), the electric field was found to be 3.7 V/m. The induced peak electric 
fields (Epeak) were measured in triplicate for each modulated frequency and 
perpendicular distance from the plasma ray tube. No significant frequency-dependent 
variation in the induced electric fields was observed, and the mean of all 
measurements at each plane was taken as the peak electric field at that location.  
 
The induced peak electric fields (background subtracted) were then used to estimate 
the peak magnetic flux density (B, in T) from Epeak = 2hπfB (Bassen et al., 1992); where 
f is the transmitted frequency (27.125  106 Hz), and 2h is the depth of the cell culture 
medium (0.0035 m). The induced current densities (J) were also estimated from the 
peak electric fields, according to the relation J = σE, assuming a conductivity (σ) of 1.5 
S/m for the cell culture medium (Bassen et al., 1992). The estimated induced peak 
electric fields, magnetic flux density, and current density are presented in Table 2.1.   
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Table 2.1: Estimated peak electric field (E), magnetic flux density (B), and current density (J) induced 
at a distance (d) from the axis of a 29-cm plasma ray tube. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
d (cm) E (V/m) B (T) J (A/m2) 
19.0 6.69  1.15 22.43 10.04 
21.4 5.25  0.69 17.60 7.88 
23.8 3.24  1.11 10.86 4.86 
27.0 2.01  0.51 6.74 3.02 
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2.6. Clonogenic Cell Survival Assay 
 
Table 2.1 summarises the cell numbers that were seeded per dose point for each cell 
line. For each experiment and dose point, cell culture flasks were prepared in triplicate. 
 
Table 2.2: Summary of cell numbers seeded at each radiation dose of X-rays delivered acutely. 
 
Cell line                
Dose (Gy) 
0 1 2 4 6 8 10 
MeWo 200 200 300 1000 3000 8000 15000 
Be11 200 200 300 1000 2000 5000 10000 
DU145 200 200 300 1000 2000 6000 10000 
L132 200 200 300 1000 3000 7000 15000 
 
All seeded cells were left to settle for 3 h after which they were irradiated with X-rays 
to the specified doses. The cell cultures were then incubated at 37°C in a humidified 
atmosphere (95% air, 5% CO2) for 10 days (for DU145, Be11 and L132) and 15 days 
(for MeWo) for colony formation. 
 
To terminate cultures, the growth media were decanted and colonies were washed 
with phosphate buffered saline, fixed in glacial acetic acid:methanol:water 
(1:1:8,v/v/v), stained in 0.01% amido black in fixative, washed in tap water, air-dried, 
and counted using a stereoscopic microscope (Nikon, Japan; Model #: SMZ-1B). 
Colonies containing at least 50 cells were deemed to have originated from single 
surviving cells and were scored. Cytotoxicity was assessed on the basis of a surviving 
fraction (SF) which was calculated from the relation: 
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                              SF=ncol(t)/{[ncol(u)/ncell(u)]  ncell(t)}         (2.1), 
 
where ncol(t) and ncol(u) denote the number of colonies counted in treated and 
untreated samples, respectively. ncell(t) and ncell(u) are the number of cells seeded in 
treated and untreated cultures, respectively.  
 
Three independent experiments were performed for each cell line. To generate 
clonogenic cell survival curves, the determined mean surviving fractions (SF) were 
fitted to the linear-quadratic (LQ) model of the form: 
 
                                 SF= exp[-αD-βD2]                                  (2.2), 
 
where α and  are the linear and quadratic coefficients, respectively, and D is the dose 
in Gy. Cellular radiosensitivity was expressed in terms of several indicators, namely, 
the surviving fraction at 2 Gy (SF2), the surviving fraction at 6 Gy (SF6), the mean 
inactivation dose (?̅?), and the / ratio. The SF2 and SF6 represent low and high dose 
sensitivity, respectively. The mean inactivation dose, which is the area under the 
survival-dose response curve plotted on a linear-linear scale, represents the sensitivity 
over low-high doses. The / ratio depicts both the steepness and curvature of a 
survival curve, and is the dose at which the linear and quadratic components of cell 
killing are equal.  
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2.7. Effect of Radiofrequency Fields on Plating Efficiency  
 
To assess if the various radiofrequencies have any cytotoxic effect on the cells, plating 
efficiencies determined from unirradiated cultures with no exposure to RFF were 
compared with those from unirradiated cultures exposed to RFF, to obtain a plating 
efficiency modifying factor: 
 
𝑀𝐹𝑝𝑙𝑎𝑡𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =
𝑛𝑐𝑜𝑙(0 𝐺𝑦)/𝑛𝑐𝑒𝑙𝑙(0 𝐺𝑦)
𝑛𝑐𝑜𝑙(0 𝐺𝑦+𝑅𝐹𝐹)/𝑛𝑐𝑒𝑙𝑙(0 𝐺𝑦+𝑅𝐹𝐹)
        (2.3), 
 
where ncol and ncell are the number of colonies counted and cells seeded, respectively. 
 
2.8. Radiomodulatory Effects of Radiofrequencies 
 
To investigate the influence of RFF exposure on radiosensitivity, stock cell cultures 
from all 4 cell lines were trypsinised and cells seeded in numbers as listed in Table 2.1 
per 25-cm2 tissue culture flask and left to settle for 3 h. The cells were subsequently 
exposed to radiofrequency fields modulated at 100 and 1000 Hz for 30 min, as 
described in Section 2.5, 2 h prior to or following 1-10 Gy of X-ray irradiation (Section 
2.4). Unirradiated cultures with and without RF field exposure were used as controls 
for RFF and X-ray treatment, respectively. The cell cultures were then processed for 
colonies to form. Surviving fractions were determined for three independent 
experiments for each radiation dose point and frequency, and corresponding survival 
curves were generated as per Equation 2.2. The modulatory effect of radiofrequency 
fields on radiosensitivity was expressed as a survival modifying factor (MFsurvival), given 
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as the ratio of surviving fractions at a dose of X-rays (or the mean inactivation dose, 
?̅?) in the absence and presence of RFF: 
 
𝑀𝐹𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 =
𝑆𝐹(𝑋−𝑟𝑎𝑦𝑠)
𝑆𝐹(𝑅𝐹𝐹+𝑋−𝑟𝑎𝑦𝑠)
  𝑜𝑟 
?̅?(𝑋−𝑟𝑎𝑦𝑠)
?̅?(𝑅𝐹𝐹+𝑋−𝑟𝑎𝑦𝑠)
       (2.4). 
 
The criteria for inhibition, no effect, and enhancement of radiosensitivity by RFF are 
MF<1.0, MF=1.0, and MF>1.0, respectively.  
 
To test for potential radiomodulatory effects of fields modulated at higher frequencies, 
the procedure described here was repeated with fields modulated at 2000 and 4000 
Hz when combined with 2 and 6 Gy. The corresponding surviving fractions were 
derived and compared with those when cell cultures were treated with X-rays alone, 
according to Equation 2.4. 
 
2.9. Assessment of Metabolic Activity  
 
Treatment-induced changes in cellular metabolic activity were measured, using the 3-
(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. For this, 100 
000 cells in 100 µl of medium were seeded per well into a 96-well cell culture plate 
(triplicate per sample), with detachable wells to enable selective treatment and 
reassembly. The cells were incubated for 2 hours to attach. Four wells were then used 
for each treatment option, namely, treatment with radiofrequency waves modulated by 
either 100 Hz or 1000 Hz, 2 h prior to or post 6 Gy irradiation with X-rays. After 
treatment, the wells were reassembled and the cultures incubated at 37°C in a 
humidified atmosphere (95% air, 5% CO2) for 30 min (for measurement of early 
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changes in metabolic activity) and 18 h (for measurement of late changes in metabolic 
activity).  
 
After each incubation period, 10 µl of 5 mg/ml MTT solution (prepared by dissolving 
MTT powder in PBS) was then added to each well and incubated at 37°C in a 
humidified atmosphere (95% air, 5% CO2) for 4 h in the dark. In this period, 
metabolically active cells reduce MTT to generate purple formazan crystals. One 
hundred microlitres of dimethyl sulfoxide (DMSO) was then added to each well to 
solubilise the crystals, and the plate was incubated for 10 min at room temperature in 
the dark. The absorbances (optical densities, OD) were then determined for samples 
and blanks at a wavelength of 560 nm, using the microplate spectrophotometer 
(Labtech International, Sussex, UK; Model #: LT-4000). 
 
Data were expressed as relative metabolic activities, given as the ratios of mean 
absorbances in samples treated with X-rays to those obtained for the negative controls 
(OD6Gy/OD0Gy); or the ratios of mean absorbances in triplicate samples treated with 
combinations of X-rays and RFF to those obtained for the positive controls 
(OD6Gy+RFF/OD0Gy+RFF). The ratios of the former to the latter (or modifying factors) were 
then taken to represent the mode by which RFF modified metabolic activity in 
irradiated cells. A modifying factor of >1, 1, or <1 indicates a reduction, no effect, or 
an enhancement in metabolic activity in irradiated cells by RFF, respectively.   
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2.10. Measurement of Cytosolic Superoxide Dismutase (SOD) Activity 
 
To evaluate the role of superoxide radicals generated in RFF-mediated cellular 
response to X-ray treatment, cells were seeded in 25 cm2 tissue culture flasks and 
incubated until they reached ~80% confluence. The cells were subsequently exposed 
to a 1000-Hz modulated radiofrequency field for 30 min, 2 h prior to or following a 6 
Gy X-ray irradiation. The field was chosen for this assay as it showed the largest effect 
on radiosensitivity in all cell lines. The treated cells were incubated at 37°C in a 
humidified atmosphere (95% air, 5% CO2) for 2 h. The cells were then harvested by 
gentle trypsinisation. One million cells were harvested and washed 3 times by 
centrifugation in ice cold PBS at 250  g for 10 min and discarding the supernatant. 
The cells were then resuspended in 0.5 ml of ice cold PBS and homogenised, using a 
BeadBug 3 microtube homogeniser (Whitehead Scientific, Western Cape, South 
Africa; Serial #: 1184070298). Homogenisation was performed in plastic tubes 
containing 1.5 mm high impact zirconium beads at 4000 RPM in 3 bursts each 30 
seconds long with a 30 second rest between bursts. The cells were then centrifuged 
at 1500  g for 10 minutes at 4°C and the supernatants collected. The supernatants 
were spun again at 10 000  g for 15 min at 4°C and the supernatants collected to 
measure cytosolic SOD 1,Cu/Zn.  
 
Standards were prepared by serial dilution from the stock provided with the SOD kit 
(Life Technologies Corporation, Frederick, MD, USA; cat # EIASODC) to achieve 
concentrations of 4, 2, 1, 0.5, 0.25, 0.125, 0.0625 U/ml. The samples were diluted at 
a ratio of 1:1 (sample:dilution buffer, v/v). Ten microlitres each of diluted samples and 
standards were pipetted, in triplicate, into pre-labelled wells of a 96-well plate, 50 µl of 
Stellenbosch University https://scholar.sun.ac.za
44 
 
1X substrate was added to each well, followed by 25 µl of 1X xanthine oxidase, and 
the plate was incubated at 25°C for 20 min. The plates were then read at 450 nm on 
a spectrophotometer (Labtech International, Sussex, UK; Model #: LT-4000). A 
standard curve was plotted from the absorbances obtained from the standard 
samples, and was used to determine sample concentrations of SOD.  
 
Data were further expressed as relative SOD activities, given as the ratios of mean 
SOD concentrations in triplicate samples treated with X-rays to those obtained for the 
negative controls (SOD6Gy/SOD0Gy); or the ratios of mean concentrations in samples 
treated with combinations of X-rays and RFF to those obtained for the positive controls 
(SOD6Gy+1000Hz/SOD1000Hz or SOD1000Hz+6Gy /SOD1000Hz). The ratios of the former to the 
latter (or modifying factors) were then taken to represent the mode by which RFF 
modified SOD activity in irradiated cells. A modifying factor of >1, 1, or <1 indicates a 
reduction, no effect, or an enhancement in SOD activity in irradiated cells by RFF, 
respectively. 
 
2.11. Assessment of DNA Damage Response 
 
To evaluate the role of RFF exposure in radiation-induced DNA damage response, the 
micronucleus formation assay was used (Akudugu et al., 2000). For this, exponentially 
growing cells were trypsinised into single-cell suspensions and seeded (40 000 cells 
per plate) into 35-mm plastic petri dishes containing 22 mm glass cover slips, to a final 
medium volume of 2 ml, and incubated at 37°C in a humidified atmosphere (95% air, 
5% CO2) for 2 h. The cells were exposed to radiofrequency fields (100 or 1000 Hz) 
and X-rays (0 or 2 Gy) as in Sections 2.4 and 2.5. Immediately after exposure, and not 
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later than 30 min, the cultures were treated with cytochalasin-B dissolved in DMSO to 
a final concentration of 2 µg/ml and incubated.  
 
In a preliminary micronucleus experiment, using the lung fibroblasts (L132), it was 
observed that a typical 40-h incubation yielded a large proportion of multi-nucleated 
cells (Akudugu et al., 2000). As the micronucleus assay requires that micronuclei be 
scored in only binucleated cells, it was necessary to determine the doubling times of 
all cell lines to guide the timing of subsequent experiments. The doubling times for the 
L132, MeWo, Be11, and DU145 cell lines were found to be 21, 47, 28, and 30 h, 
respectively. Therefore, the cell cultures were correspondingly terminated after being 
incubated for 24, 48, 42, and 42 h, respectively. For this, the samples were fixed with 
a methanol:acetic acid mixture (3:1, v/v), air-dried and stained with acridine orange, 
and the cover slips mounted on glass microscope slides for fluorescence microscopy. 
Micronuclei in binucleated cells were counted, using a fluorescence microscope 
(LABOPHOT-2, Nikon, Japan; serial #: 465393). At least 500 binucleated cells were 
evaluated per experiment. Micronucleus frequency (MNF) was expressed as the mean 
number of micronuclei per binucleated cell. The proportion of binucleated cells and the 
nucleation index, BNI (proportion of cells with 2 main nuclei) were determined as 
indicators of cell proliferation.   
 
A micronucleus frequency-based RFF treatment related modifying factor was derived 
as follows: MFMNF = (MNF2Gy-MNFmedium)/(MNF2Gy+RFF-MNFRFF) or (MNF2Gy-
MNFmedium)/(MNFRFF+2Gy-MNFRFF), where MNFmedium and MNFRFF are the micronucleus 
frequencies of the growth medium and RFF controls, respectively. The corresponding 
modifying factor, based on binucleation, was given as: MFBNI = 
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(BNI2Gy/BNImedium)/(BNI2Gy+RFF/BNIRFF) or (BNI2Gy/BNImedium)/(BNIRFF+2Gy/BNIRFF). A 
modifying factor of >1, 1, or <1 indicates a reduction, no effect, or an enhancement in 
MNF or BNI in irradiated cells by RFF, respectively. 
 
2.12. Data analysis 
 
Data analyses were performed with GraphPad Prism software (San Diego, USA). All 
data were presented as the mean (±SEM) from three independent experiments or 
triplicate samples. Where applicable, errors were determined using appropriate error 
propagation formulae. The unpaired two-sided t-test was used to compare two data 
sets. A P < 0.05 indicates a statistically significant difference between the data sets. 
For associations, linear regression analyses were used. 
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CHAPTER 3 
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3. Results 
 
3.1. Effect of Radiofrequency Field Exposure on Plating Efficiency 
 
To determine if radiofrequency field exposure alone affects colony forming capacity, 
the plating efficiencies (PE) of the cell lines in negative (medium only) and positive 
(RFF exposed) controls were compared to obtain a modifying factor (MFPE) as follows: 
MFPE = PEmedium/PERFF. The MFPE-values for the various frequencies are presented in 
Table 3.1.  
 
Table 3.1: Summary of plating efficiency modifying factors for DU145, MeWo, Be11, and L132 following 
exposure to 100, 1000, 2000, and 4000-Hz modulated radiofrequency fields. Data are presented as the 
mean ± SEM from 3 independent experiments.  
 
Except for Be11, which seemed to exhibit an enhanced plating efficiency when 
exposed to the 4000-Hz modulated field, there was no apparent effect on the plating 
efficiency of all cell lines for all frequencies. With modifying factors very close to 1.0, it 
can be inferred that RFF treatment alone at these frequencies is not cytotoxic.  
  
Cell line 100 Hz 1000 Hz 2000 Hz 4000 Hz 
DU145 1.00 ± 0.03 0.99 ± 0.02 0.97 ± 0.04 1.02 ± 0.06 
MeWo 1.08 ± 0.15 0.94 ± 0.03  0.91 ± 0.02 0.91 ± 0.06 
Be11 1.03 ± 0.05 1.12 ± 0.06 0.94 ± 0.06 0.88 ± 0.04 
L132 0.94 ± 0.03 0.98 ± 0.04 0.94 ± 0.08 0.95 ± 0.05 
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3.2. Radiosensitivity and Radiomodulatory Effect of Radiofrequency Fields  
 
To determine cellular intrinsic radiosensitivity and evaluate the effect of radiofrequency 
fields on radiosensitivity, the clonogenic cell survival assay was used. The data for 
each cell line and frequency are described below: 
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Figure 3.1: Clonogenic survival curves for the DU145 cell line after X-ray irradiation alone (black) and 
in combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). RFF exposure 
was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival curves were obtained by 
fitting data from three independent experiments to the linear-quadratic model (Equation 2.2). 
 
The dose response curves for the prostate cancer cell line are presented in Figure 3.1. 
The radiobiological parameters are summarised in Table 3.2. The data show that the 
100-Hz modulated field either had no effect or slightly enhanced radiosensitivity at 
doses between 2 and 6 Gy (Figure 3.1A, Table 3.2). Treatment of cells with this 
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radiofrequency field prior to and after 2 Gy of X-rays resulted in 1% (P = 0.8307) and 
9% (P = 0.0621) more cell killing, respectively. Similarly, the corresponding reductions 
in cell survival at 6 Gy were 2% (P = 0.0579) and 4% (P = 0.0099). The mean 
inactivation doses following RFF exposure before and after X-ray treatment also did 
not differ markedly from that for X-ray exposure alone. These data suggest that 
exposure of the DU145 cells to the 100-Hz modulated RFF after X-ray irradiation was 
more radiosensitising than when cells were pre-exposed to this radiofrequency field, 
but the differences were not statistically significant (0.0507  P  0.1050). The slight 
sensitisation, or lack thereof, is also reflected by the modifying factor not differing 
significantly from 1.0, as presented in Table 3.3. 
 
Table 3.2: Summary of radiobiological parameters for the DU145 cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic coefficients of cell 
inactivation, respectively. ?̅? denotes the mean inactivation dose (area under the cell survival curve). 
Data are presented as the mean ± SEM from 3 independent experiments. 
*errors less than 0.01; actual values were used for error propagation in Table 3.3.  
 
 
Treatment SF2 SF6 ?̅? (Gy) α (Gy-1) β (Gy-2) 
X-rays 0.68±0.03 0.15±0.01 3.44±0.07 0.13±0.03 0.03±0.00* 
100 Hz + X-rays 0.67±0.03 0.13±0.01  3.36±0.11 0.13±0.02 0.04±0.00* 
X-rays + 100 Hz 0.59±0.01 0.11±0.01 3.13±0.02 0.20±0.03 0.03±0.01 
1000 Hz + X-rays 0.69±0.10 0.10±0.02 3.16±0.14 0.08±0.06 0.06±0.01 
X-rays + 1000 Hz 0.67±0.09 0.09±0.02 3.23±0.12 0.10±0.06 0.05±0.01 
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Table 3.3: Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.2 for the DU145 cell line according to Equation (2.4). Errors were calculated 
using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
 
When cells were treated with the 1000-Hz field in combination with X-rays, 
radiosensitisation was more pronounced at doses higher than 2 Gy, as shown by the 
much more prominent “bendiness” of combination curves compared to the X-ray only 
curve (Figure 3.1B). At 2 Gy both pre- and post-exposure to this field did not influence 
the radiosensitivity, yielding modifying factors of ~1.0 (Table 3.3). On the other hand, 
treatment of cells with RFF prior to and after 6 Gy of X-rays resulted in 5% (P = 0.0684) 
and 6% (P = 0.0212) more cell killing, respectively (Table 3.2), with corresponding 
modifying factors of greater than 1.0 (Table 3.3). Regardless of the parameter 
considered, there was no significant difference in radiosensitisation between pre- and 
post-exposure to this RFF (0.6221  P  0.8543).    
 
The data in Table 3.2 show that the X-rays+100 Hz treatment yield a ~1.5-fold larger 
linear component of cell killing ( = 0.20 Gy-1) than those for the 100 Hz+X-rays and 
X-ray treatments ( = 0.13 Gy-1). The -components of cell killing for these treatments 
are similar. The / ratios for the 100 Hz+X-rays and X-rays+100 Hz were found to be 
Treatment MFSF2 MFSF6 𝑴𝑭?̅? 
100 Hz + X-rays 1.01 ± 0.06 1.15 ± 0.12  1.02 ± 0.04 
X-rays + 100 Hz 1.15 ± 0.05 1.36 ± 0.15 1.10 ± 0.02 
1000 Hz + X-rays 0.99 ± 0.15 1.50 ± 0.32 1.09 ± 0.05 
X-rays + 1000 Hz 1.02 ± 0.14 1.67 ± 0.39 1.07 ± 0.05 
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3.25 ± 0.54 and 6.67 ± 2.44, respectively, and did not differ from that for the X-ray 
treatment alone (4.33 ± 1.11 Gy). However, the 1000 Hz+X-rays and X-rays+1000 Hz 
treatments resulted in decreased linear and increased quadratic components of cell 
killing. The resulting / ratios were 1.33 ± 1.02 and 2.00 ± 1.26 Gy, respectively, 
indicating a ~2-fold reduction in ratio in the 1000-Hz modulated RFF treatment.  
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Figure 3.2: Clonogenic survival curves for the MeWo cell line after X-ray irradiation alone (black) and 
in combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). RFF exposure 
was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival curves were obtained by 
fitting data from three independent experiments to the linear-quadratic model (Equation 2.2). 
 
The cell survival curves in Figure 3.2 show that pre- and post-exposure to the 100-Hz 
modulated radiofrequency wave had no effect on radiosensitivity in the MeWo cell line, 
regardless of radiation dose (Figure 3.2A). Most all of the derived parameters, namely, 
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SF2, SF6, ?̅?, α, and β were found to be similar for both treatment sequences (Table 
3.4), giving modifying factors of approximately 1.0 (Table 3.5).  
 
Table 3.4: Summary of radiobiological parameters for the MeWo cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic coefficients of cell 
inactivation, respectively. ?̅? denotes the mean inactivation dose (area under the cell survival curve). 
Data are presented as the mean ± SEM from 3 independent experiments. 
*errors less than 0.01; actual values were used for error propagation in Table 3.5.  
 
Pre- and post-exposure to the 1000-Hz modulated RFF led to lower cell survival at low 
and high doses (Figure 3.2B). Treatment of the MeWo cells with this RFF prior to and 
after 2 Gy of X-rays led to 13% (P = 0.0657) and 15% (P = 0.0277) more cell killing, 
respectively (Table 3.4). This translates to radiosensitivity modifying factors of greater 
than 1.0 (Table 3.5). Correspondingly, either treatment combination at 6 Gy resulted 
in a 2% (0.0040  P  0.0078) more cell killing, yielding dose modifying factors of 
greater than 2.0. The mean inactivation doses for RFF exposure before and after X-
ray treatment were found to be significantly lower than that for X-ray treatment alone 
(0.0025  P  0.0191). However, based on all parameters, there was no statistically 
Treatment SF2 SF6 ?̅? (Gy) α (Gy-1) β (Gy-2) 
X-rays 0.43±0.04 0.03±0.00* 3.37±0.03 0.34±0.04 0.04±0.01 
100 Hz + X-rays 0.39±0.10 0.03±0.02  2.20±0.31 0.42±0.12 0.04±0.01 
X-rays + 100 Hz 0.37±0.10 0.03±0.02 2.28±0.32 0.46±0.12 0.04±0.02 
1000 Hz + X-rays 0.30±0.03 0.01±0.00* 2.10±0.07 0.53±0.05 0.04±0.01 
X-rays + 1000 Hz 0.28±0.02 0.01±0.00* 2.01±0.04 0.56±0.05 0.04±0.01 
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significant difference between RFF exposure before and after X-ray treatment (0.1269 
 P  0.5750).  
 
Table 3.5: Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.4 for the MeWo cell line according to Equation (2.4). Errors were calculated 
using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
 
The absence of a modulatory effect in the 100 Hz+X-rays and X-rays+100 Hz 
treatment can also be due to their respective / ratios (10.50 ± 3.99 and 11.50 ± 6.48 
Gy) not differing markedly from that of the X-ray treatment (/ = 8.50 ± 2.35 Gy). The 
 coefficients for the pre-exposure and post-exposure of MeWo cells to the 1000-Hz 
modulated RFF were about 1.5-fold larger than that of the X-ray only treatment (Table 
3.4). The corresponding / ratios were 13.25 ± 3.54 and 14.00 ± 3.72 Gy.  
 
 
  
Treatment MFSF2 MFSF6 𝑴𝑭?̅? 
100 Hz + X-rays 1.10 ± 0.30 1.00 ± 0.56  1.53 ± 0.22 
X-rays + 100 Hz 1.16 ± 0.33 1.16 ± 0.71 1.48 ± 0.21 
1000 Hz + X-rays 1.43 ± 0.20 2.42 ± 0.32 1.61 ± 0.06 
X-rays + 1000 Hz 1.54 ± 0.18 3.22 ± 0.49 1.68 ± 0.04 
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Figure 3.3: Clonogenic survival curves for the Be11 cell line after X-ray irradiation alone (black) and in 
combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). RFF exposure 
was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival curves were obtained by 
fitting data from three independent experiments to the linear-quadratic model (Equation 2.2). 
 
The survival curves in Figure 3.3 show that pre- and post-exposure of Be11 cells to 
RFF modulated by 100 and 1000 Hz are rendered more radiosensitive compared to 
when the cells were exposed to X-rays only. This is evident by the much steeper (~4.4- 
to 6.9-fold larger -component of cell killing) survival curves in combination treatments 
compared to the survival curves from X-ray only (Table 3.6). The -coefficients in all 
cases varied over a narrow range (0.02-0.06 Gy-2). The resulting / ratios for the 100 
Hz+X-rays, X-rays+100 Hz, 1000 Hz+X-rays, and X-rays+1000 Hz treatments were 
11.00 ± 3.55, 10.00 ± 3.91, 31.00 ± 16.01, and 30.00 ± 15.65 Gy, respectively, while 
that for the X-ray only treatment emerged as 1.50 ± 1.19 Gy. 
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Table 3.6: Summary of radiobiological parameters for the Be11 cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic coefficients of cell 
inactivation, respectively. ?̅? denotes the mean inactivation dose (area under the cell survival curve). 
Data are presented as the mean ± SEM from 3 independent experiments. 
*errors less than 0.01; actual values were used for error propagation in Table 3.7.  
 
The radiosensitivity modifying efficacy of the 100- and 1000-Hz modulated 
radiofrequency fields was not affected by sequences of treatment (i.e. whether RFF 
exposure occurred before or after X-ray treatment), as the respective cell survival 
curves were congruent (Figure 3.3). Based on SF2, SF6, and ?̅?, the 1000-Hz 
modulated field was ~1.45-, ~1.76-, and ~1.33-fold more potent in radiosensitising the 
Be11 cells than the 100-Hz modulated field (Table 3.7).  
 
  
Treatment SF2 SF6 ?̅? (Gy) α (Gy-1) β (Gy-2) 
X-rays 0.67±0.05 0.08±0.01 3.06±0.03 0.09±0.07 0.06±0.01 
100 Hz + X-rays 0.36±0.04 0.02±0.01  2.24±0.28 0.44±0.09 0.04±0.01 
X-rays + 100 Hz 0.41±0.11 0.03±0.01 2.38±0.34 0.40±0.12 0.04±0.01 
1000 Hz + X-rays 0.26±0.04 0.01±0.00* 1.67±0.12 0.62±0.08 0.02±0.01 
X-rays + 1000 Hz 0.27±0.03 0.01±0.00* 1.77±0.06 0.61±0.07 0.02±0.01 
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Table 3.7: Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.6 for the Be11 cell line according to Equation (2.4). Errors were calculated 
using error propagation formulae for ratios. 
 
 
 
 
 
 
 
  
Treatment MFSF2 MFSF6 𝑴𝑭?̅? 
100 Hz + X-rays 1.86 ± 0.25 4.10 ± 1.42  1.37 ± 0.17 
X-rays + 100 Hz 1.63 ± 0.46 3.28 ± 1.55 1.29 ± 0.18 
1000 Hz + X-rays 2.58 ± 0.44 6.31 ± 2.22 1.83 ± 0.13 
X-rays + 1000 Hz 2.48 ± 0.33 6.83 ± 2.07 1.73 ± 0.06 
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 Figure 3.4: Clonogenic survival curves for the L132 cell line after X-ray irradiation alone (black) and in 
combination with 100-Hz (A) and 1000-Hz (B) modulated radiofrequency fields (RFF). RFF exposure 
was performed 2 h prior to (blue) or after (red) X-ray treatment. The survival curves were obtained by 
fitting data from three independent experiments to the linear-quadratic model (Equation 2.2). 
 
 
From Figure 3.4, it is apparent that both 100-Hz and 1000-Hz modulated fields have 
radiomodulatory effects on L132 cells, as evidenced by the steeper cell survival curves 
from the combination treatments when compared to that of the X-ray only treatment. 
Table 3.8 summarises the radiobiological parameters for these treatments. Exposure 
to the 100-Hz modulated field prior to or after X-ray treatment led to 17% (P = 0.0168) 
and 32% (P = 0.1221) reduction in SF2, respectively (Figure 3.4A, Table 3.8). The 
corresponding decreases in SF6 were 50% (P = 0.0838) and 67% (P = 0.0364). 
Combined treatment also reduced the mean inactivation dose by up to 18%, although 
this reduction did not reach statistical significance (P  0.2275). 
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Table 3.8: Summary of radiobiological parameters for the L132 cell line. SF2 and SF6 denote the 
surviving fraction at 2 and 6 Gy, respectively. α and β are the linear and quadratic coefficients of cell 
inactivation, respectively. ?̅? denotes the mean inactivation dose (area under the cell survival curve). 
Data are presented as the mean ± SEM from 3 independent experiments. 
*errors less than 0.01; actual values were used for error propagation in Table 3.9.  
 
Exposure to the 1000-Hz modulated radiofrequency field, regardless of sequence, 
further sensitised L132 cells to X-rays (Figure 3.4B, Table 3.8). SF2, SF6, and ?̅? were 
reduced by up to 62% (0.0071  P  0.0086), 92% (0.0111  P  0.0127), and 50% 
(0.0170  P  0.0245), respectively.  The modifying factors obtained from these 
parameters are summarised in Table 3.9. Based on SF2, SF6, and ?̅?, combined 
treatment with the 1000-Hz modulated RFF was found to be correspondingly 1.9-, 4.5, 
and 1.6-fold more potent, respectively, in radiosensitising the L132 cells than the 100-
Hz modulated field.   
 
  
  
Treatment SF2 SF6 ?̅? (Gy) α (Gy-1) β (Gy-2) 
X-rays 0.66±0.07 0.12±0.02 3.33±0.42 0.16±0.05 0.04±0.01 
100 Hz + X-rays 0.55±0.02 0.06±0.00*  2.90±0.08 0.22±0.03 0.04±0.00* 
X-rays + 100 Hz 0.45±0.08 0.04±0.01 2.72±0.11 0.33±0.09 0.04±0.01 
1000 Hz + X-rays 0.29±0.04 0.01±0.00* 1.82±0.07 0.56 ±0.07 0.03±0.01 
X-rays + 1000 Hz 0.25±0.04 0.01±0.00* 1.67±0.04 0.61±0.08 0.03±0.01 
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Table 3.9: Modifying factors (MF), relative to X-ray treatment alone, derived from the SF2, SF6, and ?̅? 
values presented in Table 3.8 for the L132 cell line according to Equation (2.4). Errors were calculated 
using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
The radiosensitisation seen in the 100 Hz+X-rays and X-rays+100 Hz treatments was 
also apparent in the increase in the / ratio from 4.00 ± 1.60 Gy (X-ray only) to 5.50 
± 0.92 and 8.25 ± 3.05 Gy, respectively. The more pronounced radiosensitisation in 
the 1000 Hz+X-rays and X-rays+1000 Hz treatments was reflected in even larger 
ratios of 18.67 ± 6.65 and 20.33 ± 7.28, respectively. 
 
3.3. Summary of Relative Cellular Radiosensitivity  
 
To obtain an overall indication of the relative radiosensitivity of the cell lines, a rank 
order was constructed based on SF2, SF6, and 𝐷,̅  as presented in Table 3.10. Except 
for combined treatment with the 1000-Hz modulated radiofrequency field, ?̅? emerged 
as the parameter providing the most consistent ranking of radiosensitivity. Using the 
frequency of cell lines under each rank for X-ray treatment alone, they may be 
arranged in order of increasing radiosensitivity as: DU145  L132  Be11  MeWo.  
 
Treatment MFSF2 MFSF6 𝑴𝑭?̅? 
100 Hz + X-rays 1.20 ± 0.13 1.90 ± 0.40  1.15 ± 0.15 
X-rays + 100 Hz 1.47 ± 0.30 3.22 ± 1.12 1.22 ± 0.16 
1000 Hz + X-rays 2.28 ± 0.40 9.67 ± 3.14 1.83 ± 0.24 
X-rays + 1000 Hz 2.64 ± 0.51 12.89 ± 3.14 1.99 ± 0.26 
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Table 3.10: Summary of relative radiosensitivity of DU145, L132, Be11, and MeWo cell lines based on 
SF2, SF6, and ?̅?. 
 
Radiosensitivity ranking for the combined treatment with the 100-Hz modulated RFF 
was similar to the intrinsic radiosensitivity ranking. The ranking obtained from the 
combined treatment with the1000-Hz modulated RFF markedly differed from the 
intrinsic ranking, and emerged as DU145  MeWo  L132  Be11, with the MeWo 
cells showing an increased treatment resistance.  
 
Treatment Parameter Increasing Radiosensitivity  
 
X-rays 
SF2 DU145 Be11 L132 MeWo 
SF6 DU145 L132 Be11 MeWo 
?̅? DU145 L132 Be11 MeWo 
 
100 Hz + X-rays 
SF2 DU145 L132 MeWo Be11 
SF6 DU145 L132 MeWo  Be11 
?̅? DU145 L132 Be11 MeWo 
 
X-rays + 100 Hz 
SF2 DU145 L132 Be11 MeWo 
SF6 DU145 L132 Be11  MeWo 
?̅? DU145 L132 Be11 MeWo 
 SF2 DU145 MeWo  L132 Be11 
1000 Hz + X-rays SF6 DU145  MeWo  L132 Be11 
 ?̅? DU145 MeWo  L132 Be11 
 
X-rays + 1000 Hz 
SF2 DU145 MeWo  Be11 L132 
SF6 DU145  Be11  MeWo L132 
?̅? DU145 MeWo  Be11 L132 
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3.4. Effect of Radiofrequency Fields Modulated at Higher Frequencies on 
Radiosensitivity  
 
To assess whether the radiosensitisation seen in concomitant treatment with 
radiofrequency fields modulated at 100 and 1000 Hz was persistent at fields 
modulated at higher frequencies, RFF modulated at 2000 and 4000 Hz were evaluated 
for their effect on cell survival at 2 and 6 Gy. The survival data for the DU145 cell line 
are presented in Figure 3.5.  
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Figure 3.5: Cell survival data of the DU145 cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy.  
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Use of higher modulatory frequencies did not affect radiosensitivity at 2 Gy (Figure 
3.5A). However, the field modulated with 2000 Hz further radiosensitised the DU145 
cells at 6 Gy, while the 4000-Hz modulated field resulted in a recovery of cell survival 
to levels comparable to those obtained for the 1000-Hz modulated field (Figure 3.5B). 
 
The survival data for the MeWo cell line are shown in Figure 3.6. The 2000-Hz 
modulated field appears to induce some recovery in cell survival at 2 Gy (Figure 3.6A).  
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Figure 3.6: Cell survival data of the MeWo cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy.  
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On the other hand, use of a 4000-Hz modulated field led to an additional 
radiosensitisation relative to that obtained for the 1000-Hz modulated field. At 6 Gy, 
RFF modulated at 2000 and 4000 Hz induced a recovery in cell survival (Figure 3.6B). 
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Figure 3.7: Cell survival data of the Be11 cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy.  
 
Figure 3.7 shows the cell survival data for the Be11 cell line when treated with RFF 
modulated at various frequencies. At 2 Gy, fields modulated at 2000 and 4000 Hz 
Stellenbosch University https://scholar.sun.ac.za
65 
 
showed a slight radiosensitisation as seen for the 100-Hz modulated field (Figure 
3.7A). Interestingly, combined treatment with higher frequency fields resulted in a 
pronounced recovery of cell survival at 6 Gy (Figure 3.7B). 
 
From Figure 3.8, it is apparent that concomitant treatment of the L132 cell line with 
fields modulated at higher frequency (2000 and 4000 Hz) results in better cell survival 
at 2 and 6 Gy compared to 1000 Hz combination treatments. 
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Figure 3.8: Cell survival data of the L132 cell line for various radiofrequency field treatments at (A) 2 
Gy and (B) 6 Gy.  
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3.5. Effect of Radiofrequency Fields on Radiation-Induced Metabolic Changes 
 
The MTT assay was used to assess the potential effect of the radiofrequency fields on 
early (30 min) and late (18 h) radiation-induced changes in metabolic activity of the 
four cell lines. It was further evaluated whether such changes play a role in long-term 
cell survival. For this, treatment-induced changes in metabolic activity was expressed 
as fold changes (relative metabolic activity) relative to appropriate controls (Section 
2.9). These changes are presented as follows:  
 
DU145 
 
Figure 3.9 is an illustration of the fold changes in metabolic activity in the prostate 
cancer cell line, DU145, for the various treatments. While treatment with 6 Gy or 6 
Gy+1000-Hz modulated RFF resulted in a reduction in early metabolic activity by about 
60%, a 6 Gy+100-Hz modulated RFF treatment yielded an enhancement (~1.3-fold) 
in metabolic activity (Figure 3.9A). No effect on early metabolic activity was apparent, 
when cells were exposed to RFF prior to X-ray treatment.  
 
Similarly, no effect on late metabolic activity was observed when cells were treated 
with either X-rays alone or X-rays followed by a 100-Hz modulated RFF (Figure 3.9B). 
However, exposure to a 100-Hz modulated field followed by X-ray treatment or an X-
ray treatment followed by exposure to a 1000-Hz modulated RFF resulted in increased 
(~1.3-fold) late metabolic activity. In contrast to the absence of an effect at an early 
time point, pre-exposure to the 1000-Hz modulated field followed by X-ray treatment 
led to a reduction of ~32% in late metabolic activity (Figure 3.9B).  
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Figure 3.9: Relative metabolic activities for the prostate cancer cell line, DU145: (A) 30 min and (B) 18 
h after treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz modulated 
radiofrequency fields.  
 
Determination of dose modifying factors (MF), as described in Section 2.9, revealed 
that regardless of RFF frequency and sequence of combination with X-rays, early 
metabolic activity was enhanced (MF < 1.0; Table 3.11). Late metabolic activity was 
6 
G
y
10
0 
H
z 
+ 
6 
G
y
6 
G
y 
+ 
10
0 
H
z
10
00
 H
z+
6 
G
y
6 
G
y 
+ 
10
00
 H
z
0.25
0.50
0.75
1.00
1.25
1.50
0
30 minutesA
Treatment
R
e
la
tiv
e
 m
e
ta
b
o
lic
 a
c
tiv
ity
6 
G
y
10
0 
H
z 
+ 
6 
G
y
6 
G
y 
+ 
10
0 
H
z
10
00
 H
z+
6 
G
y
6 
G
y 
+ 
10
00
 H
z
0.25
0.50
0.75
1.00
1.25
1.50
0
18 hoursB
Treatment
R
e
la
tiv
e
 m
e
ta
b
o
lic
 a
c
tiv
ity
Stellenbosch University https://scholar.sun.ac.za
68 
 
also enhanced in the 100-Hz modulated RFF+X-ray and X-ray+1000-Hz modulated 
RFF treatments, while a reduction (MF > 1.0; Table 3.11) was seen in the 1000-Hz 
modulated RFF+X-ray treatment. Exposure of cells to the 100-Hz modulated RFF after 
irradiation had no effect on late metabolic activity.  
 
Table 3.11: Modifying factors (MF), relative to X-ray treatment alone, derived from the relative metabolic 
activities presented in Figure 3.9 for the DU145 cell line, as described in Section 2.9. Errors were 
calculated using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
 
MeWo 
 
The data in Figure 3.10 show changes in metabolic activity in the melanoma cell line, 
MeWo, following the different treatments. Except for the X-ray+1000-Hz modulated 
RFF treatment that resulted in a reduction, the other treatments either had no effect 
or induced an increase in early metabolic activity (Figure 3.10A). Within experimental 
uncertainty, all treatments had no effect on late metabolic activity (Figure 3.10B). 
Treatment 30 min 18 h 
100 Hz + 6 Gy 0.39 ± 0.09 0.75 ± 0.18 
6 Gy + 100 Hz 0.32 ± 0.04 0.99 ± 0.38 
1000 Hz + 6 Gy 0.40 ± 0.09 1.42 ± 0.29 
6 Gy + 1000 Hz 0.89 ± 0.22 0.69 ± 0.15 
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Figure 3.10: Relative metabolic activities for the melanoma cell line, MeWo: (A) 30 min and (B) 18 h 
after treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz modulated 
radiofrequency fields. 
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The dose modifying factors presented in Table 3.12 demonstrate no marked changes 
in metabolic activity, except for the 100-Hz and 1000-Hz modulated RFF+X-ray 
treatments which resulted in ~1.2- and 1.4-fold enhancements in early metabolic 
activity, respectively, when compared with that of X-ray only treatment. 
 
Table 3.12: Modifying factors (MF), relative to X-ray treatment alone, derived from the relative metabolic 
activities presented in Figure 3.10 for the MeWo cell line, as described in Section 2.9. Errors were 
calculated using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
 
Be11 
 
X-ray treatment alone resulted in about 50% reduction and similar extent of 
enhancement in early and late metabolic activity in the Be11 cell line (Figure 3.11). 
Combined X-ray and RFF treatments of these cells, regardless of sequence, 
enhanced early metabolic activity (Figure 3.11A, Table 3.13). On the other hand, all 
combination treatments with both RFF led to a reduction in late metabolic activity 
(Figure 3.11B, Table 3.13). 
Treatment 30 min 18 h 
100 Hz + 6 Gy 0.85 ± 0.22 1.05 ± 0.18 
6 Gy + 100 Hz 1.09 ± 0.33 1.27 ± 0.36 
1000 Hz + 6 Gy 0.73 ± 0.09 0.98 ± 0.15 
6 Gy + 1000 Hz 1.37 ± 0.20 1.08 ± 0.20 
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Figure 3.11: Relative metabolic activities for the melanoma cell line, Be11: (A) 30 min and (B) 18 h 
after treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz modulated 
radiofrequency fields. 
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Table 3.13: Modifying factors (MF), relative to X-ray treatment alone, derived from the relative 
metabolic activities presented in Figure 3.11 for the Be11 cell line, as described in Section 2.9. Errors 
were calculated using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
 
 
L132 
 
The relative metabolic activity data presented in Figure 3.12 show that X-ray irradiation 
of the normal lung fibroblasts, L132, resulted in about 60% increase in early metabolic 
activity (Figure 3.12A). Inclusion of RFF exposure either had no effect (6 Gy+100-Hz 
modulated RFF) or reduced (all other combined treatments) metabolic activity. On the 
other hand, a 6-Gy exposure alone resulted in about 40% reduction in late metabolic 
activity (Figure 3.12B). The 100-Hz modulated RFF+X-ray treatment enhanced late 
metabolic activity. However, the other combined treatments resulted in reduced 
activity, with the 1000-Hz modulated RFF being the most effective (Figure 3.12B). 
Treatment 30 min 18 h 
100 Hz + 6 Gy 0.28 ± 0.09 2.27 ± 0.60 
6 Gy + 100 Hz 0.35 ± 0.04 2.04 ± 0.34 
1000 Hz + 6 Gy 0.65 ± 0.13 1.91 ± 0.21 
6 Gy + 1000 Hz 0.55 ± 0.12 1.56 ± 0.16 
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Figure 3.12: Relative metabolic activities for human lung fibroblasts, L132: (A) 30 min and (B) 18 h 
after treatment to 6 Gy of X-rays alone or in combination with 100-Hz and 1000-Hz modulated 
radiofrequency fields. 
 
The dose modifying factors in Table 3.14 show that combined X-ray and RFF 
treatment of the lung fibroblasts, regardless of sequence, led to a reduction (MF > 1.0) 
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in early metabolic activity. A similar reduction in late metabolic activity was also seen 
when cells were concomitantly treated with the 1000-Hz modulated RFF. However, 
combined treatment with 100-Hz modulated RFF increased (MF < 1.0) late metabolic 
activity. 
  
Table 3.14: Modifying factors (MF), relative to X-ray treatment alone, derived from the relative metabolic 
activities presented in Figure 3.12 for the L132 cell line, as described in Section 2.9. Errors were 
calculated using error propagation formulae for ratios. 
 
 
 
 
 
 
 
 
3.6. Relationship between Radiosensitivity and Metabolic Activity 
 
To evaluate if treatment induced changes in metabolic activity play a role in the 
modulatory effects that radiofrequency fields have on cellular radiosensitivity, the 
modifying factors derived from the MTT assay were plotted as a function of those 
obtained from the clonogenic cell survival assay. The data in Figure 3.13 show a weak 
correlation [Y=(0.140.06)X+(0.200.39); R2 = 0.4767; P = 0.058] between the 100-
Hz RFF induced radiosensitisation and changes in early metabolic activity (Figure 
3.13A), where cell lines displaying high levels of radiosensitisation on the basis of 
Treatment 30 min 18 h 
100 Hz + 6 Gy 2.44 ± 0.82 0.52 ± 0.15 
6 Gy + 100 Hz 1.85 ± 0.54 0.83 ± 0.30 
1000 Hz + 6 Gy 4.19 ± 1.18 1.47 ± 0.49 
6 Gy + 1000 Hz 2.55 ± 0.75 2.00 ± 0.71 
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clonogenic survival tended to have reduced (MF > 1.0) metabolic activity. No 
relationship was apparent between early metabolic activity and cell survival when the 
1000-Hz modulated RFF was employed. 
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Figure 3.13: Plot of modifying factors from metabolic activity (measured 30 min after treatment) as a 
function of modifying factors from clonogenic cell survival for 4 cell lines: (A) combined treatment with 
100-Hz modulated RFF and (B) combined treatment with 1000-Hz modulated RFF. Dashed lines 
represent the 95% confidence interval. 
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Figure 3.14: Plot of modifying factors from metabolic activity (measured 18 h after treatment) as a 
function of modifying factors from clonogenic cell survival for 4 cell lines: (A) combined treatment with 
100-Hz modulated RFF and (B) combined treatment with 1000-Hz modulated RFF. Dashed lines 
represent the 95% confidence interval. 
 
No link emerged between cell survival and late changes in metabolic activity for 
combined treatment with the 100-Hz modulated RFF (Figure 3.14A). However, if only 
the malignant cell lines are considered, a strong correlation is apparent, where an 
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increase in radiosensitisation is mirrored by a reduction in metabolic activity. Similarly, 
a correlation [Y=(0.080.03)X+(0.920.20); R2 = 0.5851; P = 0.027] emerged between 
changes in late metabolic activity and radiosensitisation by the 1000-Hz modulated 
radiofrequency field (Figure 3.14B). 
 
 
3.7. Effect of a Radiofrequency Field on Radiation-Induced Changes in 
Superoxide Dismutase (SOD) Activity 
 
Superoxide dismutase (SOD) activity was measured in cell cultures, 2 h after 
treatment with 6 Gy of X-rays alone or in combination with a 1000-Hz modulated 
radiofrequency field. Figure 3.15 is the generated standard curve, as described under 
Section 2.10, from which SOD concentrations (an indicator of SOD activity) were 
determined.  
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Figure 3.15: Standard curve used to determine the concentration of cytosolic superoxide dismutase 
(SOD) from absorbance measurements (Section 2.10). 
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The data in Figure 3.16 show that X-ray exposure alone resulted in ~40% increase in 
SOD activity in DU145 cells. Exposure of cells to the 1000-Hz modulated RFF led to 
~2.7-fold increase in SOD activity, relative to the medium control. Relative to RFF 
exposure alone, X-ray irradiation prior to RFF treatment led to about 40% reduction in 
SOD activity, while a reversed treatment sequence increased SOD activity by a similar 
extent.  
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Figure 3.16: Superoxide dismutase concentration in DU145 cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control (medium; red 
horizontal line) and X-ray+RFF treatment was compared with positive control (1000 Hz; blue horizontal 
line), to generate relative SOD activities which were used to derive modifying factors, as described in 
Section 2.10. 
  
Irradiation of the MeWo cells to 6 Gy yielded a 25% reduction in SOD activity, relative 
to the medium control (Figure 3.17). Relative to the medium control, RFF treatment 
alone resulted in only ~8% increase in SOD activity. The 6 Gy+1000-Hz modulated 
Stellenbosch University https://scholar.sun.ac.za
79 
 
RFF and 1000-Hz modulated RFF+6 Gy treatments also reduced SOD activity by 
~25% and 16% relative to the 1000-Hz control, respectively.   
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Figure 3.17: Superoxide dismutase concentration in MeWo cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control (medium; red 
horizontal line) and X-ray+RFF treatment was compared with positive control (1000 Hz; blue horizontal 
line), to generate relative SOD activities which were used to derive modifying factors, as described in 
Section 2.10. 
 
The data shown in Figure 3.18 are the SOD activities in Be11 cells for the various 
treatments. Treatment of cells with 6 Gy or a 1000-Hz modulated RFF led to ~47% 
reduction or ~36% increase in SOD activity relative to the medium control, 
respectively. When compared to the 1000-Hz control, treatment with 6 Gy+1000-Hz 
modulated RFF and 1000-Hz modulated RFF+6 Gy reduced SOD activity by ~85% 
and 50%, respectively.   
Stellenbosch University https://scholar.sun.ac.za
80 
 
M
ed
iu
m
6 
G
y
10
00
 H
z
10
00
 H
z+
6 
G
y
6 
G
y+
10
00
 H
z
0.2
0.4
0.6
0.8
0
Be11
Treatment
S
O
D
 (
U
/m
L
)
 
Figure 3.18: Superoxide dismutase concentration in Be11 cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control (medium; red 
horizontal line) and X-ray+RFF treatment was compared with positive control (1000 Hz; blue horizontal 
line), to generate relative SOD activities which were used to derive modifying factors, as described in 
Section 2.10. 
 
When the normal lung fibroblasts were exposed to 6 Gy or the 1000-Hz modulated 
RFF, a slight increase of ~6% SOD activity was observed (Figure 3.19). Relative to 
the 1000-Hz control, 6 Gy+1000-Hz modulated RFF and 1000-Hz modulated RFF+6 
Gy treatments resulted in ~8% and 11% reduction in SOD activity, respectively.   
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Figure 3.19: Superoxide dismutase concentration in L132 cells following RFF exposure and X-ray 
irradiation singly or in combination. X-ray treatment was compared with negative control (medium; red 
horizontal line) and X-ray+RFF treatment was compared with positive control (1000 Hz; blue horizontal 
line), to generate relative SOD activities which were used to derive modifying factors, as described in 
Section 2.10. 
 
The dose modifying factors, on the basis of SOD activity, as described in Section 2.10, 
are presented in Table 3.15. For the DU145 cell line, treatment with a combination of 
the 1000-Hz modulated RFF and 6 Gy did not change SOD activity (MF ≈ 1.0) when 
compared with the 6-Gy irradiation alone. However, when these cells were irradiated 
prior to RFF exposure, a larger than 2-fold reduction in SOD activity was observed. A 
similar treatment response was noted in the Be11 line.  
 
For the MeWo cell line, pre-exposure to the RFF resulted in about 12% increase (MF 
< 1.0) in SOD activity. A treatment sequence reversal did not affect radiation-induced 
SOD activity. 
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For the lung fibroblasts, L132, both combination treatments yielded about 20% 
reduction (MF > 1.0) in SOD activity. 
 
Table 3.15: Modifying factors (MF), relative to X-ray treatment alone, derived from the superoxide 
dismutase (SOD) activities presented in Figures 3.16-3.19 for the DU145, MeWo, Be11, and L132 cell 
lines, as described in Section 2.10. Errors were calculated using error propagation formulae for ratios. 
 
 
  
Treatment DU145 MeWo Be11 L132 
1000 Hz+X-rays 0.97 ± 0.09 0.88 ± 0.05 1.08 ± 0.30 1.20 ± 0.06 
X-rays+1000 Hz 2.43 ± 0.18 0.99 ± 0.06 3.53 ± 1.71 1.16 ± 0.06 
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3.8. Relationship between Radiosensitivity and SOD Activity 
 
To test whether treatment induced changes in superoxide dismutase (SOD) activity 
are linked to the modulatory effects seen in cellular radiosensitivity when the 1000-Hz 
modulated radiofrequency field (RFF) was applied, the modifying factors derived from 
SOD activity were plotted against those obtained from clonogenic cell survival. Figure 
3.20 shows no relationship [Y=(0.00180.0935)X+(1.520.63); R2 < 0.0001; P = 
0.9856] between the RFF induced radiosensitisation and changes in SOD activity.  
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Figure 3.20: Plot of modifying factors from superoxide dismutase activity (measured 2 hours after 
treatment) as a function of modifying factors from clonogenic cell survival for 4 cell lines, following 
combined treatment with a 1000-Hz modulated RFF. Dashed lines represent the 95% confidence 
interval. 
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3.9. Effect of Radiofrequency Fields on Radiation Induced Micronucleus 
Frequency 
 
The cytokinesis-block micronucleus assay was used to determine if radiofrequency 
fields had an effect on radiation induced DNA damage and block of cell proliferation. 
For this, treatment induced changes in micronucleus yield and binucleation were 
assessed. Data for the four cell lines are presented as follows:  
 
DU145 
 
The data presented in Figure 3.21 show that exposure of the prostate cancer cell line, 
DU145, to the 100-Hz and 1000-Hz modulated radiofrequency fields does not result 
in a significant change in background (medium control) micronucleus yield. Exposure 
of cells to the 100-Hz modulated RFF prior to or after 2 Gy of X-rays did not affect 
micronucleus yield (Figure 3.21A). While pre-exposure of cells to the 1000-Hz 
modulated RFF did not affect radiation induced micronucleus frequency, RFF 
exposure after irradiation resulted in ~18% reduction in DNA damage (Figure 3.21B). 
 
The binucleation indices in the DU145 cells for the various treatments are presented 
in Figure 3.22. For the 100-Hz modulated RFF, no marked changes were observed in 
cellular capacity to go through a cell division (Figure 3.22A). Also, a 2-Gy of X-rays or 
a 1000-Hz modulated RFF treatment did not affect binucleation (Figure 3.22B). 
However, when this RFF field was combined with 2 Gy of X-rays, a reduction in cell 
proliferation of more than 30% was found. 
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Figure 3.21: Micronucleus yield in the prostate cancer cell line, DU145, after treatment with 2 Gy of X-
rays alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field.  
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Figure 3.22: Binucleation index in the prostate cancer cell line, DU145, after treatment with 2 Gy of X-
rays alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field.  
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MeWo 
 
Exposure of MeWo cells to both 100-Hz and 1000-Hz modulated RFF resulted in ~1.8-
fold increase in micronucleus yield over background (Figure 3.23). Combined 
treatment with 2 Gy of X-rays and the 100-Hz modulated RFF led to ~1.2-fold increase 
in micronucleus yield, regardless of treatment sequence (Figure 3.23A).  
M
ed
iu
m
10
0 
H
z
2 
G
y
10
0 
H
z+
2 
G
y
2 
G
y+
10
0 
H
z
0.25
0.50
0.75
1.00
1.25
1.50
0
A
Treatment
M
ic
ro
n
u
le
u
s
 f
re
q
u
e
n
c
y
M
ed
iu
m
10
00
 H
z
2 
G
y
10
00
 H
z+
2 
G
y
2 
G
y+
10
00
 H
z
0.25
0.50
0.75
1.00
1.25
1.50
0
B
Treatment
M
ic
ro
n
u
le
u
s
 f
re
q
u
e
n
c
y
 
Figure 3.23: Micronucleus yield in the melanoma cell line, MeWo, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field. 
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When the 1000-Hz modulated RFF was combined with 2 Gy of X-rays, a 2-fold 
increase in DNA damage emerged (Figure 3.23B).  
 
Figure 3.24A shows no effect on binucleation index when MeWo cells were exposed 
to X-rays or the 100-Hz modulated RFF alone. An approximately 18% reduction in 
binucleation was obtained from the combination treatments. 
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Figure 3.24: Binucleation index in the melanoma cell line, MeWo, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field. 
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While a 2-Gy of X-rays treatment alone or combined treatment with the 1000-Hz 
modulated RFF resulted in an expected decline in binucleation, exposure to the RFF 
alone increased cell proliferation by more than 10% (Figure 3.24B).    
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Be11 
 
Exposure of Be11 cells to the 100-Hz and 1000-Hz modulated RFF resulted in ~2.0-
and ~4.0-fold increases in micronucleus yield compared to background, respectively 
(Figure 3.25).  
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Figure 3.25: Micronucleus yield in the melanoma cell line, Be11, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field. 
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Combination treatment with the 100-Hz modulated RFF prior to or after 2 Gy of X-rays 
led to ~24% and ~30% reduction in micronucleus yield, respectively (Figure 3.25A). 
On the other hand, the 1000-Hz modulated RFF had no effect on radiation induced 
micronucleus frequency (Figure 3.25B). 
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Figure 3.26: Binucleation index in the melanoma cell line, Be11, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field. 
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A slight reduction in binucleation was seen when cells were exposed to the 100-Hz or 
1000-Hz modulated RFF alone (Figure 3.26). The decrease in binucleation at 2 Gy 
was reversed to levels close to those in background (medium and RFF control), when 
cells were concomitantly treated with the 100-Hz modulated RFF (Figure 3.26A). A 
similar, but less pronounced, recovery in binucleation was observed when cells were 
treated with a combination of X-rays and the 1000-Hz modulated RFF (Figure 3.26B). 
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L132 
 
For the normal lung fibroblasts, L132, exposure to 100-Hz modulated RFF alone 
increased micronucleus yield, relative to background (Figure 3.27A). Combined 
treatment with this field led to up to 1.8-fold increase in micronucleus yield at 2 Gy, 
with the RFF exposure after X-ray irradiation being more damaging.  
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Figure 3.27: Micronucleus yield in the normal lung fibroblasts, L132, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field. 
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Treatment with the 1000-Hz modulated RFF alone had no impact on the background 
level of micronuclei (Figure 3.27B). As in the case of the 100-Hz modulated RFF, 
combination treatment with the 1000-Hz modulated RFF resulted in an up to 3.3-fold 
increase in micronucleus yield, with RFF exposure after 2 Gy of X-rays being more 
potent (Figure 3.27B). 
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Figure 3.28: Binucleation index in the normal lung fibroblasts, L132, after treatment with 2 Gy of X-rays 
alone or in combination with a: (A) 100-Hz and (B) 1000-Hz modulated radiofrequency field. 
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Data for binucleation in the L132 cell line are presented in Figure 3.28. No effect on 
binucleation is apparent when cells were exposed to either the 100-Hz or 1000-Hz 
modulated RFF alone. Combined treatment with these radiofrequency fields reduced 
binucleation, relative to that obtained for the 2 Gy only treatment, with RFF exposure 
after X-ray irradiation being less potent in arresting cell proliferation. 
 
Treatment induced modifying factors, based on micronucleus yield, as described in 
Section 2.11, are presented in Table 3.16. In the DU145 and Be11 cell lines, combining 
radiofrequency fields with X-ray irradiation either had no effect (MF ≈ 1.0) or resulted 
in small reductions (MF > 1.0) in micronucleus yield.  Similar treatment of the MeWo 
and L132 cell lines led to ~1.14 to 3.33-fold enhancement (MF < 1.0) in micronucleus 
frequency.   
 
Table 3.16: Modifying factors (MF), relative to X-ray treatment alone, derived from the micronucleus 
frequency presented in Figures 3.21, 3.23, 3.25, and 3.7 for the DU145, MeWo, Be11, and L132 cell 
lines, respectively, as described in Section 2.11. Errors were calculated using error propagation 
formulae for ratios. 
 
 
 
 
 
 
 
 
  
Treatment DU145 MeWo Be11 L132 
100 Hz+2 Gy 1.07 ± 0.19 0.88 ± 0.11 1.16 ± 0.23 0.83 ± 0.26 
2 Gy+100 Hz 0.99 ± 0.25 0.79 ± 0.11 1.47 ± 0.19 0.55 ± 0.22 
1000 Hz+2 Gy 0.96 ± 0.16 0.53 ± 0.07 1.03 ± 0.18 0.41 ± 0.07 
2 Gy+1000 Hz 1.21 ± 0.17 0.62 ± 0.08 1.10 ± 0.40 0.30 ± 0.08 
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3.10. Relationship between Radiosensitivity and Micronucleus Yield   
 
To assess whether the radiosensitivity modifying effects seen when cells were 
concomitantly treated with radiofrequency fields and X-rays are influenced by changes 
in the level of DNA damage, the modifying factors derived from micronucleus yield 
were plotted against those determined from clonogenic cell survival. Figure 3.29A 
shows a weak trend [Y=(0.360.35)X+(0.490.47); R2 = 0.1532; P = 0.3376] where 
cell lines that are more radiosensitised produce lower yields of micronuclei, following 
combined treatment with the 100-Hz modulated RFF. Exclusion of the Be11 cell line 
which seems to be an outlier yields a strong correlation [Y=(-1.080.22)X+(2.120.25); 
R2 = 0.8597; P = 0.0078; Figure 3.29A; blue line] between the RFF induced 
radiosensitisation and DNA damage, whereby highly radiosensitised cell lines tend to 
express elevated levels (MF < 1.0) of micronuclei frequency.  
 
A similarly weak correlation [Y=(-0.150.19)X+(1.050.38); R2 = 0.0903; P = 0.4695] 
was found for radiosensitisation and micronucleus yield for the combined treatment 
with the 1000-Hz modulated RFF, with more radiosensitised cell lines expressing 
higher levels of micronuclei (Figure 3.29B). Again, exclusion of the Be11 cell line, 
strengthens this correlation [Y=(-0.450.13)X+(1.420.22); R2 = 0.7691; P = 0.0218; 
Figure 3.29B; blue line]. 
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Figure 3.29: Plot of modifying factors from micronucleus frequency (MNF) at 2 Gy as a function of 
modifying factors from surviving fraction at 2 Gy for 4 cell lines: (A) combined treatment with 100-Hz 
modulated RFF and (B) combined treatment with 1000-Hz modulated RFF. Dashed lines represent the 
95% confidence interval. 
 
As described in Section 2.11, the modifying factors derived from binucleation indices 
are presented in Table 3.17. A combined treatment of the MeWo and L132 cell lines 
with radiofrequency fields and X-ray irradiation either had no effect (MF ≈ 1.0) or 
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resulted in small reductions (MF > 1.0) in binucleation. Similar treatment of the DU145 
and Be11 cell lines resulted in ~1.1 to 1.4-fold enhancement (MF < 1.0) in cell 
proliferation.   
 
Table 3.17: Modifying factors (MF), relative to X-ray treatment alone, derived from the binucleation 
indices presented in Figures 3.22, 3.24, 3.26, and 3.8 for the DU145, MeWo, Be11, and L132 cell lines, 
respectively, as described in Section 2.11. Errors were calculated using error propagation formulae for 
ratios. 
 
 
 
 
 
 
 
 
3.11. Relationship between Radiosensitivity and Binucleation 
 
The role of cell proliferation in the modulation of radiosensitivity by radiofrequency 
fields was assessed by plotting modifying factors derived from binucleation indices 
against those derived from clonogenic cell survival. Figure 3.30A demonstrates a weak 
trend [Y=(-0.520.34)X+(1.750.46); R2 = 0.2786; P = 0.1788] where an increase in 
radiosensitisation is mirrored by enhanced (MF < 1.0) binucleation, after combined 
treatment with the 100-Hz modulated RFF. A similarly weak, but reversed trend 
[Y=(0.200.20)X+(0.720.39); R2 = 0.1421; P = 0.3573] emerged for the 1000-Hz 
modulated RFF combined treatment (Figure 3.30B).  However, as in the case of 
Treatment DU145 MeWo Be11 L132 
100 Hz+2 Gy 0.91 ± 0.07 1.32 ± 0.28 0.73 ± 0.04 1.46 ± 0.18 
2 Gy+100 Hz 0.84 ± 0.06 1.32 ± 0.24 0.72 ± 0.04 1.20 ± 0.16 
1000 Hz+2 Gy 0.80 ± 0.08 1.04 ± 0.19 0.88 ± 0.09 1.78 ± 0.48 
2 Gy+1000 Hz 0.81 ± 0.06 1.23 ± 0.19 0.76 ± 0.07 1.45 ± 0.49 
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micronucleus yield, exclusion of the Be11 cell line strengthens the correlation 
[Y=(0.510.13)X+(0.350.23); R2 = 0.7976; P = 0.0165; Figure 3.30B; blue line] 
between the RFF induced radiosensitisation and cell proliferation, where more 
radiosensitised cell lines tend to have reduced (MF >1.0) binucleation.  
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Figure 3.30: Plot of modifying factors from binucleation index (BNI) at 2 Gy of X-rays as a function of 
modifying factors from surviving fraction at 2 Gy for 4 cell lines: (A) combined treatment with 100-Hz 
modulated RFF and (B) combined treatment with 1000-Hz modulated RFF. Dashed lines represent the 
95% confidence interval. 
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4. Discussion 
 
Radiation therapy (RT) is considered the first line of treatment for most superficial 
cancers, as these malignancies tend to respond well to radiation. The use of 
hypofractionated treatment may be beneficial for certain tumours, but this poses a 
normal tissue toxicity challenge as hypofractionation can cause severe side-effects 
from which the patient may not be able to recover. A possible approach to circumvent 
this challenge is the use of radiation modifying agents that can potentiate the tumour 
inactivating effects of ionising radiation and, therefore, lead to a reduction of radiation 
dose and normal tissue toxicity. Chemotherapeutic drugs are widely used in 
conjunction with radiotherapy, but do induce severe undesirable systemic effects 
(Azim et al., 2011; Palumbo et al., 2013; Alarid-Escudero et al., 2017).   
 
Although magnetic fields have long been suggested as potential enhancers of 
radiation effects, only a handful of studies have been reported (Miyakoshi et al., 1999; 
Ding et al., 2000; Artacho-Cordón et al., 2013 for review). Studies on the combined 
biological effects of radiofrequency fields (RFF) and ionising radiation are virtually non-
existent. The use of RFF as an adjuvant to radiotherapy may be beneficial, as they 
have been shown to exhibit in vitro radiosensitising and radioprotective effects on 
malignant and normal cells, respectively, with the possibility of a significant dose 
reduction (Chinhengo et al., 2018; 2019). However, there is a need to understand the 
potential mechanisms by which these RFF influence radiosensitivity so that they can 
be employed efficiently as radiotherapy modulators. The main goal of radiotherapy is 
to kill tumour cells and spare normal tissue, and a good modifying agent would be one 
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that sensitises the tumour to radiation while protecting the normal tissue. Here, the 
clonogenic cell survival assay was used as a measure of radiosensitivity. The 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), superoxide dismutase 
(SOD) and micronucleus assays were used to assess the possible mechanisms by 
which RFF influence the radiosensitivity of cells. The findings reported herein are 
intended to validate my initial observations (Chinhengo et al., 2018; 2019), and to 
assess candidate factors underlying the radiomodulatory effects of radiofrequency 
fields.  
 
4.1. Intrinsic Radiosensitivity and Radiomodulatory Effect of Radiofrequency 
Fields 
 
This study sought to compare intrinsic radiosensitivity to RFF modulated 
radiosensitivity, using  the p53 mutant, human malignant melanoma MeWo cell line; 
the p53 wild-type, human melanoma Be11 cell line; the p53 mutant, human prostate 
cancer DU145 cell line; and the p53 wild-type, human normal lung epithelial L132 cell 
line. The intrinsic radiosensitivity data summarised in Table 3.10 show the DU145 to 
be the most radioresistant cell line and MeWo the most radiosensitive, giving a rank 
order of increasing radiosensitivity of DU145  L132  Be11  MeWo, when the cell 
survival parameters SF2, SF6, and ?̅? were collectively taken into account. Within the 
limits of experimental uncertainty, the SF2-values obtained here are consistent with 
those reported previously reported for the DU145 (Slabbert et al., 1996; Maleka et al., 
2015), L132 (Roos et al., 2000), Be11 (Binder et al., 2000; Akudugu et al., 2004a), 
and MeWo (Binder et al., 2000) cell lines, indicating no unusual radiation response. 
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As stated before, an appropriate radiomodulator is one that is non-toxic on its own. 
These data demonstrate that cellular exposure to radiofrequency fields, irrespective 
of frequency, does not have a notable cytotoxic effect, as the plating efficiency of the 
cell line remained virtually unchanged (Table 3.1). This is not surprising, as several 
other studies have not demonstrated cytotoxic effects in a variety of cellular systems 
even at extremely high radiofrequency fields (Hirose et al., 2006; Lantow et al., 2006; 
Joubert et al., 2007). As such, radiofrequency fields could, therefore, find application 
as efficient radiation modulators in radiotherapy or radiation protection. 
 
In this investigation, combined treatment with the 100-Hz modulated RFF and X-rays 
does not markedly affect the radiosensitivity ranking of the cell lines (Table 3.10). Pre- 
and post-exposure to 100 Hz only slightly altered radiosensitivity, with DU145 and 
MeWo the most radioresistant and most radiosensitive cell lines, respectively, for the 
most part. The exception being when cells were pre-exposed to 100 Hz, which 
rendered Be11 the most radiosensitive cell line. Pre- and post-exposure to the 1000-
Hz modulated RFF, however, augmented the radiosensitivity of the Be11 and L132 
cell lines significantly more than the DU145 and MeWo cell lines, making Be11 and 
L132 more radiosensitive than MeWo, with DU145 the most radioresitant in all 
treatments. The marked radiosensitisation in the human lung fibroblasts (Table 3.9) 
contrasts the finding of the initial study, using Chinese hamster lung fibroblasts (V79), 
which showed that RFF can act as radioprotectors in normal cells (Chinhengo et al., 
2018). This suggests that a potential application of the 1000-Hz modulated RFF as an 
adjuvant in the clinical setting might not be generally appropriate, as it may significantly 
aggravate radiation-induced normal tissue toxicity.   
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The disparity in radiomodulation by RFF seems to be partly influenced by the p53 
status of the cell line. The p53 wild-type cell lines (L132 and Be11) were consistently 
more sensitised compared to the p53 mutant cell lines (MeWo and DU145), as is 
apparent from the modifying factors presented in Tables 3.3, 3.5, 3.7, and 3.9. The 
slight sensitisation of the p53 mutant cell lines used here and the radioprotection 
demonstrated in the apparently normal V79 cells in a previous study (Chinhengo et 
al., 2018) suggest that RFF influence radiosensitivity in ways that may be independent 
of p53 function. It is worth noting that p53 is also mutated and non-functional in V79 
cells (Chaung et al., 1997). However, the significant sensitisation of p53 wild-type cell 
lines suggests that RFF might target the p53 survival pathway, influencing it to 
enhance radiosensitivity. This would contrast with the report by Hirose and colleagues 
suggesting that radiofrequency field in the GHz range do not affect p53 
phosphorylation (Hirose et al., 2006). However, the effects of radiofrequency fields on 
macromolecules are largely frequency-dependent (Agulan et al., 2015). The fields 
used in the current study may enhance radiation-induced damage to macromolecules, 
but damaged cells that are p53 mutant may evade p53-mediated apoptosis, dying 
through other modes (Tait et al., 2014) or surviving, while their p53 wild-type 
counterparts are eliminated through a p53-mediated apoptotic process. This further 
emphasises the need for caution in a possible combination of RFF with ionising 
radiation in cancer therapy, as a significant component of cancers are p53 mutated 
and such mutations might sometimes infer gain of certain protective functions (Muller 
and Vousden, 2013). It is also possible that RFF exposure activates other genes in 
different survival pathways, the influence on survival depending on whether genes in 
the targeted pathway are functional or altered, rendering them dysfunctional. The 
Stellenbosch University https://scholar.sun.ac.za
105 
 
presence of a dysfunctional gene in a survival pathway brings discontinuity to a 
pathway.  
 
The influence of RFF seems to be cell line and frequency dependent (Chinhengo et 
al., 2018), more so at higher radiation doses. All the radiofrequency fields evaluated 
here affect the radiosensitivity to more or less the same extent. DU145 is sensitised 
the most by the 2000-Hz modulated field at high radiation doses, with the 100-, 1000-
and 4000-Hz modulated fields having the same influence on the cell line. MeWo, Be11 
and L132 are sensitised the most by 1000-Hz modulated field in combination with high 
radiation doses, with the 100-, 2000- and 4000-Hz having the same influence on these 
cell lines. These results suggest that any potential use of RFF, as an adjuvant to 
radiation therapy, needs to be regulated and guided by the characteristics of each 
cancer e.g. type and p53 status. This, especially that RFF modulated at higher 
frequencies tended to promote cell survival at the higher radiation dose of 6 Gy 
(Figures 3.5 – 3.8). Such radioprotection by fields modulated at high frequency could 
have significant implications for the potential use of RFF in hypofractionation settings 
where large fractional doses are employed.  
 
4.2. Effect of Radiofrequency Fields on Radiation-Induced Changes in Metabolic 
Activity and its Relation to Overall Cell Survival. 
 
To determine the effect of RFF on X-ray induced changes in metabolic activity, relative 
metabolic activities were determined at 30 min and 18 h, and used to derive modifying 
factors, as described in Section 2.9. The expectation was for the more radiosensitised 
cell lines to exhibit the relatively higher metabolic activity (increased metabolic activity, 
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represented here by MFMTT < 1.0) and vice versa, as there is evidence to suggest that 
reduced metabolic rates lead to radioresistance (Luk and Sutherland, 1987; Heller and 
Raaphorst, 1993; Moeller et al., 2005). The data in Figure 3.13 (especially for the 100-
Hz modulated RFF) seem to reflect the opposite, with a trend towards cell lines that 
were more radiosensitised by RFF exposure showing the larger reductions in 
metabolic activity in relation to radiation treatment alone, regardless of treatment 
sequence. There is no link between intrinsic radiosensitivity and metabolic rate in 
untreated cell cultures, suggesting that the observed trend may be due to treatment 
related alterations in metabolic rate. Within the first hour of treatment, changes in 
metabolic activity may be triggered to support processes like DNA repair.  
 
This relationship between metabolic rate and radiosensitisation persisted, especially 
for the cancer cell lines, when metabolic activity was assessed at a much later time 
point (Figure 3.14). At 18 h post-treatment, increased cellular metabolism may be 
thought as supporting processes, such as proliferation, while a reduction might signal 
a cell cycle arrest. The phenomenon of radiofrequency field-induced increase in 
metabolic activity may be due to the claim that electromagnetic fields can cause cells 
to move from inactive phases of the cell cycle to the more active G2/M phases, with 
associated elevations in proliferation (Velizarov et al., 1999; Sun et al., 2009). An 
enhanced proliferation could make cells vulnerable to radiation damage and lead to a 
high level of radiosensitisation. However, the effects elicited by electromagnetic fields 
seem to be much dependent on cell type. While high frequency RFF have been shown 
to induce significant levels of cell cycle arrest in neuronal cells (Buttiglione et al., 2007), 
no such effects were demonstrated in fibroblasts and glioma cells (Higashikubo et al., 
Stellenbosch University https://scholar.sun.ac.za
107 
 
2001). These differential influences of electromagnetic fields can lead to either 
radiosensitisation, radioprotection, or no effect on cellular radiosensitivity. 
 
These results suggest that metabolic activity may be a determinant of long-term 
survival. Assessment of how radiofrequency fields affect radiation-induced cell killing 
in an expanded panel of cell lines could clarify the importance of p53 status in 
radiomodulation by RFF.  
 
4.3. Effect of Radiofrequency Fields on Radiation-Induced Changes in 
Superoxide Dismutase (SOD) Activity and its Relation to Overall Cell Survival. 
 
Reactive oxygen species (ROS) plays an important role in cellular signalling and has 
a dual role in cancer. ROS can facilitate cancer cell proliferation, survival, and 
adaptation to hypoxia while, on the other hand, ROS can cause oxidative stress, 
leading to cell death (López-Lózaro, 2007; Pan et al., 2009; Gupta et al., 2012). 
Reactive oxygen species is produced because of increased metabolic activity in cells 
and the dysfunction of mitochondria. Electromagnetic fields have been reported to 
influence the production of ROS in cells (Lai and Singh, 2010; Morabito et al., 2010; 
Kovacic and Somanathan, 2010), and its concentration may either enhance survival 
of the cells or cause macromolecule damages leading to cell death. Superoxide 
dismutase (SOD) is one of the enzymes responsible for removing or converting 
reactive oxygen species to less harmful compounds and the concentration of SOD is 
relative to the ROS levels in the cell.  In this work, the effect of a 1000-Hz modulated 
radiofrequency field and 6 Gy of X-rays on the SOD concentration was assessed and 
deemed to signify the ROS levels in response to treatment. 
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Unlike changes in metabolic activity that seemed to be correlated with radiomodulatory 
effects of RFF exposure across cell lines, no link was apparent between alterations in 
SOD activity and RFF-mediated radiosensitisation (Figure 3.20). This finding is not 
surprising, given the multifunctional features of reactive oxygen species (López-
Lózaro, 2007; Pan et al., 2009; Gupta et al., 2012). Superoxide dismutase activity was 
only markedly reduced (MFSOD > 2.0) in the p53 mutant DU145 and the p53 wild-type 
Be11 cells, when cells were pre-exposed to the radiofrequency field. No effect was 
apparent in the other treatments and cell lines, indicating that RFF-mediated changes 
in radiation-induced SOD activity do not appear to depend on p53 status or treatment 
sequence.  
 
Although superoxide dismutase has been known to play a key role in regulating 
cellular metabolism (Sarsour et al., 2012), the current study has not identified a link 
between SOD and metabolic activity. The modes by which changes in SOD and 
metabolic activity may impact on radiomodulatory effects of radiofrequency fields 
appear to be unrelated.  
 
4.4. Effect of Radiofrequency Fields on Radiation-Induced Micronucleus 
Frequency, and the Possible Impact on Cell Survival. 
 
Reports on the capacity of radiofrequency fields at inducing micronuclei are mixed. 
While some studies do not demonstrate elevated levels of micronuclei in cellular 
systems following RFF exposure (Vijayalaxmi et al., 2001; Bisht et al., 2002; 
McNamee et al., 2002), others have shown enhanced micronucleus formation 
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(Koyama et al., 2003; 2004). The slight elevation in micronucleus formation seen in 
this study may be due to the much lower frequencies used.  
 
From the summary of the micronucleus data presented in Figure 3.29, the melanoma 
cell line (Be11) is a clear outlier, being highly radiosensitised but exhibiting reduced 
levels of micronuclei (MFMNF > 1.0). Low micronucleus yield can be attributed to the 
combination treatment causing such extensive damage to the cells that they die and, 
therefore, do not present as binucleated cells with micronuclei for assessment 
(Akudugu et al., 2000). The number of lethal lesions at 2 Gy is given as the negative 
natural logarithm of SF2 (Bush and McMillan, 1993; Villa et al., 1994; Akudugu et al., 
2000). The ability of a cell to survive a certain level of micronucleus yield can be 
expressed in terms of the number of micronuclei per lethal lesion (i.e. the number of 
micronuclei that would constitute a lethal event in the cell) (Akudugu et al., 2000). 
Here, the combination treatments resulted in 0.35 - 0.52 micronuclei per lethal lesion 
in the Be11 cell line, implying that these cells are more resistant to micronuclei-
mediated death than the L132 cells (0.17 - 0.40 micronuclei per lethal lesion). For the 
DU145 and MeWo cells, the number of micronuclei per lethal lesion ranged from 0.80 
to 1.00 and 0.69 to 1.14, respectively, indicating an even higher resistance to 
micronucleus lethality. Treatment-induced reduction in micronucleus yield is, 
therefore, not due to cell death.  
 
A reduced micronucleus yield can also be a consequence of efficient DNA repair, as 
this would lead to fewer residual acentric fragments to present as micronuclei. In fact, 
Be11 cells have been shown to exhibit ~97% DNA double-strand break rejoining, 20 
h after -ray irradiation (Theron et al., 2000; Akudugu et al., 2004a). Elsewhere, the 
Stellenbosch University https://scholar.sun.ac.za
110 
 
L132 cells which also show low numbers of micronuclei per lethal lesion but an RFF-
induced increase in micronucleus yield, have been found to be equally repair proficient 
(Roos et al., 2000). However, the DU145 and MeWo cells which fall between the Be11 
and L132 cells in terms of micronucleus yield are intrinsically less efficient in DNA 
double-strand break rejoining at ~88% (El-Awady et al., 2003) and ~81% (Theron et 
al., 2000), respectively. Exclusion of the Be11 cell line yields a strong frequency-
independent correlation between RFF-mediated micronucleus yield and 
radiosensitisation, with the more radiosensitised cell lines showing increased 
micronucleus yield (Figure 3.29). The relationship between radiofrequency-mediated 
changes in micronucleus yield and DNA repair is, thus, not straightforward. However, 
these findings seem to suggest that radiofrequency exposure perturbs DNA damage 
repair processes, a phenomenon that could have important implication in radiotherapy 
and radiation protection.  
 
4.5. Effect of Radiofrequency Fields on Radiation-Induced Changes in 
Binucleation.  
 
The binucleation index can be used as an indicator of cell proliferation (Akudugu and 
Böhm, 2001; Akudugu et al., 2001; 2004b). A high binucleation index indicates a large 
proportion of cells progressing through a cell division, and vice versa. The impact of 
radiofrequency exposure on cell proliferation and cell cycle progression is not 
consistent. Although some studies have demonstrated changes in cell cycle 
progression and reductions in cell proliferation after extended exposure to RFF 
(Velizarov et al., 1999; Marinelli et al., 2004), others have failed to detect similar effects 
(Pacini et al., 2002; Gurisik et al., 2006; Sanchez et al., 2006). Based on the 
Stellenbosch University https://scholar.sun.ac.za
111 
 
binucleation data presented here, RFF exposure does not appear to have an impact 
on proliferation of DU145, MeWo, Be11, and L132 cells. The data presented in Figure 
3.10 again shows the Be11 cell line as a possible outlier, which is highly 
radiosensitised but retains a high level of cell division (MFBNI < 1.0). Elevated 
radiosensitivity in cells that continue to progress through a division after treatment may 
be related to an absence of a cell cycle block that might be required for adequate 
recovery. However, this cell line exhibits both G1- and G2-phase blocks at 12 and 16 
h, respectively, while its p53 mutated counterpart (MeWo) shows only a G2-phase 
block at about 18 h (Binder et al., 2000). Therefore, the elevated binucleation in Be11 
cannot be explained by the inexistence of a cell cycle arrest. The increased 
radiosensitivity in Be11 can be attributed to existence of the G1-phase block as arrests 
at this stage of the cell cycle are said to be responsible for high radiosensitivity 
(McIlwrath et al., 1994). 
 
Considering only the DU145, MeWo, and L132 cell lines, cells that showed reduced 
binucleation (MFBNI > 1.0) tended to be more radiosensitised. This may be due to the 
fact that cell cycle arrests in these cell lines after ~7 Gy irradiation have been noted to 
last as long as 40 h (Binder et al., 2000; Roos et al., 2000). It should be noted that 
except for the MeWo cell line (48 h), the micronucleus assay was terminated after 24 
– 42 h, based on predetermined doubling times (Section 2.11). It is, therefore, likely 
that the binucleation indices reported here represent levels that correspond to 
incomplete re-entry of cells into cycling. Nonetheless, these experiments were 
performed at 2 Gy and the residence time of cells in phase blocks can be expected to 
be much shorter, as demonstrated by Su and Little almost three decades ago (Su and 
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Little, 1993). The finding that radiofrequencies may activate proliferation in certain cell 
types could be of significance to wound healing and needs to be further interrogated.      
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CHAPTER 5 
 
 
 
 
 
 
 
  
Stellenbosch University https://scholar.sun.ac.za
114 
 
5. Conclusion 
 
Radiofrequency fields have the potential of modulating radiotherapy to improve tumour 
control. The data presented here show that radiofrequency fields are more efficient in 
modulating large fractional doses of X-rays and could find application in 
hypofractionated radiotherapy as adjuvants, especially for tumours with low alpha/beta 
ratios. This can have a significant positive impact on the management of patients with 
superficial tumours that may be resistant to low fractional doses of radiation. 
Radiofrequency fields modulate cellular radiosensitivity in a frequency- and cell type-
dependent manner. Their effects on radiosensitivity also appear to be linked to p53 
status. From the results reported here, cellular responses like metabolism, DNA 
damage processing (based on micronuclei formation), and proliferation (based on 
binucleation) seem to be underlying factors mediating the radiomodulatory effects of 
radiofrequency fields. No potential mediatory role was identified for reactive oxygen 
species.  
 
Overall, there is more than one mechanism by which radiofrequency fields can 
modulate radiosensitivity, such as amplification of radiation-induced genotoxicity, cell 
cycle arrest, and disturbance of other cellular biochemical processes that lead to 
alteration of homeostasis. Other possible ways by which RFF affect radiosensitivity 
are, interfering with the synthesis and function of charged proteins in the cell leading 
to programmed cell death or premature cell ageing, perturbation of intracellular 
calcium ions which can trigger apoptotic or necrotic cell death, and/or modulating the 
expression of Bcl-2 family proteins. Given this complexity, a potential use of 
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radiofrequency fields as a non-invasive therapeutic modality would require 
standardisation to establish reproducibility. A more detailed understanding of how 
radiofrequency fields interact with ionising radiation would also be beneficial in the 
radiation protection field. However, a major limitation of the studies described herein 
is that irradiation of cell cultures with X-rays while they are being exposed to 
radiofrequency fields is not feasible. The possibility of truly exposing cells to X-rays 
and RFF simultaneously might result in even more pronounced radiomodulatory 
effects.  
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Possible Future Avenues 
 
The importance of radiation modifiers in radiotherapy, radiation protection, and 
biological dosimetry cannot be overemphasised. When radiation modifiers are used in 
radiotherapy, the challenge is to obtain enhanced tumour response (potential 
radiosensitisation), while keeping normal tissue response unchanged or reduced 
(potential radioprotection). The extent of the biological effect of a given dose of ionising 
radiation (biological dosimetry) can be either reduced (in the case of the modifier being 
a radioprotector) or increased (in the case of the modifier being a radiosensitiser). The 
findings reported previously (Chinhengo et al., 2018; 2019), and in this study, 
demonstrate that radiofrequency fields could have desirable radiosensitising and 
radioprotective effects. The weakness of correlations, or lack thereof, between the 
radiomodulatory effects of radiofrequency fields and cellular metabolic activity, 
superoxide dismutase activity, and DNA damage (based on micronuclei induction) 
profiles, and p53 status is most likely due to the small number of cell lines studied. 
Conducting similar studies on an expanded panel of cell lines (both malignant and 
normal), and possibly, on peripheral blood lymphocytes (with assays other than the 
colony forming assay) could provide further insight into understanding the modes by 
which radiofrequency fields affect cellular responses to ionising radiation.  
 
Specifically, the following avenues could be explored: 
1. Assessment of the following after ionising radiation/radiofrequency exposure, 
using more efficient techniques like flow cytometry:  
 DNA damage processing capacity (e.g. H2AX foci assay).  
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 superoxide dismutase activity (e.g. using hydroethidine and 2′,7′‐
dichlorofluorescin). 
 metabolic activity (e.g. fluorescein diacetate activity assay).  
 p53 activity (e.g. via detection of p21). 
 cell cycle progression (e.g. measurement of DNA content).  
 
2. Repeat of (1) for:  
 radiofrequency field exposure longer than 30 min.  
 more than one fraction of radiofrequency field exposure. 
 more than one fraction of ionising radiation. 
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